EurekaMag PDF full texts Chapter 10,812

Shin, D.H.; Lee, H.Y.; Kim, H.J.; Lee, E.; Lee, K.H.; Lee, W.J.; Cho, S.S.; Baik, S.H. 1999: In situ localization of neuronal nitric oxide synthase (nNOS) mRNA in the rat retina. Neuroscience Letters 270(1): 53-55

Tsumamoto, Y.; Yamashita, K.; Takumida, M.; Okada, K.; Mukai, S.; Shinya, M.; Yamashita, H.; Mishima, H.K. 2002: In situ localization of nitric oxide synthase and direct evidence of NO production in rat retinal ganglion cells. Brain Research 933(2): 118-129

Shin, D.H.; Lee, H.Y.; Lee, H.W.; Kim, H.J.; Lee, E.; Cho, S.S.; Baik, S.H.; Lee, K.H. 1999: In situ localization of p53, bcl-2 and bax mRNAs in rat ocular tissue. Neuroreport 10(10): 2165-2167

Grote, M. 1999: In situ localization of pollen allergens by immunogold electron microscopy: allergens at unexpected sites. International Archives of Allergy and Immunology 118(1): 1-6

Himber, J.; Kling, D.ée.; Fallon, J.T.; Nemerson, Y.; Riederer, M.A. 2002: In situ localization of tissue factor in human thrombi. Blood 99(11): 4249-4250

Wenzhoefer, F.; Riess, W.; Luth, U. 2002: In situ macrofaunal respiration rates and their importance for benthic carbon mineralization on the northwestern Black Sea shelf. Ophelia 56(2): 87-100

Beaudeau, P.; Tousset, N.; Bruchon, F.; Lefèvre, A.; Taylor, H.D. 2001: In situ measurement and statistical modelling of Escherichia coli decay in small rivers. Water Research 35(13): 3168-3178

Garcia March, J.R.; Garcia Carrascosa, A.M.; Pena, A.L. 2002: In situ measurement of Pinna nobilis shells for age and growth studies: A new device. Marine Ecology 23(3): 207-217

Herberhold, C.; Faber, S.; Stammberger, T.; Steinlechner, M.; Putz, R.; Englmeier, K.H.; Reiser, M.; Eckstein, F. 1999: In situ measurement of articular cartilage deformation in intact femoropatellar joints under static loading. Journal of Biomechanics 32(12): 1287-1295

Tullberg-Reinert, H.; Jundt, G. 1999: In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochemistry and Cell Biology 112(4): 271-276

Damodaran, S. 2003: In situ measurement of conformational changes in proteins at liquid interfaces by circular dichroism spectroscopy. Analytical and Bioanalytical Chemistry 376(2): 182-188

Matsunaga, S.; Mochida, M.; Saito, T.; Kawamura, K. 2002: In situ measurement of isoprene in the marine air and surface seawater from the western North Pacific. Atmospheric Environment 36(39-40): 6051-6057

Wilcox, M.H.; Kite, P.; Mills, K.; Sugden, S. 2001: In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm. Journal of Antimicrobial ChemoTherapy 47(2): 171-175

Joshi, M.S.; Lancaster, J.R.; Liu, X.; Ferguson, T.B. 2001: In situ measurement of nitric oxide production in cardiac isografts and rejecting allografts by an electrochemical method. Nitric Oxide: Biology and Chemistry 5(6): 561-565

Deb, S., C.; Matsushige, K.; Fukushima, T.; Ikei, M.; Ozaki, N. 1999: In situ measurement of productivity and respiration in aquatic systems by a new box incubation method. Hydrobiologia 394: 129-144

Mackie, A.R.; Gunning, A.P.; Ridout, M.J.; Wilde, P.J.; Rodriguez Patino, J. 2001: In situ measurement of the displacement of protein films from the air/water interface by surfactant. Biomacromolecules 2(3): 1001-1006

Neuman, J.A.; Gao, R.S.; Fahey, D.W.; Holecek, J.C.; Ridley, B.A.; Walega, J.G.; Grahek, F.E.; Richard, E.C.; Mcelroy, C.T.; Thompson, T.L.; Elkins, J.W.; Moore, F.L.; Ray, E.A. 2001: In situ measurements of HNO3, NOy, NO, and O3 in the lower stratosphere and upper troposphere. Atmospheric Environment 35(33): 5789-5797

Warren, J.; Stanton, T.; Benfield, M.; Wiebe, P.; Chu, D.; Sutor, M. 2001: In situ measurements of acoustic target strengths of gas-bearing siphonophores. ICES Journal of: 740-749

Al-Ani, F.S.; Hamdan, F.B.; Shaikhly, K.I. 2001: In situ measurements of muscle fiber conduction velocity in Duchenne muscular dystrophy. Saudi Medical Journal 22(3): 259-261

Brotas, V.; Risgaard Petersen, N.; Serodio, J.; Ottosen, L.; Dalsgaard, T.; Ribeiro, L. 2003: In situ measurements of photosynthetic activity and respiration of intertidal benthic microalgal communities undergoing vertical migration. Ophelia 57(1): 13-26

Pepper, J.Wu.; Wright, A.O.; Kenny, J.E. 2002: In situ measurements of subsurface contaminants with a multi-channel laser-induced fluorescence system. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 58(2): 317-331

Jankowski, A.; Kim, J.H.; Collins, R.F.; Daneman, R.; Walton, P.; Grinstein, S. 2001: In situ measurements of the pH of mammalian peroxisomes using the fluorescent protein pHluorin. Journal of Biological Chemistry 276(52): 48748-48753

Marshall, Dustin John 2002: In situ measures of spawning synchrony and fertilization success in an intertidal, free-spawning invertebrate. ine Ecology Progress Series y 3; 236: 113-119

Nayar, S.; Goh, B.P.L.; Chou, L.M.; Reddy, S. 2003: In situ microcosms to study the impact of heavy metals resuspended by dredging on periphyton in a tropical estuary. Aquatic Toxicology 64(3): 293-306

Karamouzis, M.; Langberg, H.; Skovgaard, D.; Bülow, J.; Kjaer, M.; Saltin, B. 2001: In situ microdialysis of intramuscular prostaglandin and thromboxane in contracting skeletal muscle in humans. Acta Physiologica Scandinavica 171(1): 71-76

Kawaguchi, T.; Decho, A.W. 2002: In situ microspatial imaging using two-photon and confocal laser scanning microscopy of bacteria and extracellular polymeric secretions (EPS) within marine stromatolites. Marine Biotechnology 4(2): 127-131

Lee, K.M.; Ye, G.L.; Yung, W.H.; Leung, K.S.; Leung, P.C. 2001: In situ model for studying potassium currents in various growth plate chondrocyte subpopulations. Life Sciences 69(6): 721-728

George, C.H.; Sorathia, R.; Bertrand, B.M.A.; Lai, F.Anthony. 2002: In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6. Biochemical Journal 370(Pt 2): 579-589

Hicks, M.B.; Zhou, G.X.; Lieberman, D.R.; Antonucci, V.; Ge, Z.; Shi, Y.-J.; Cameron, M.; Lynch, J.E. 2003: In situ moisture determination of a cytotoxic compound during process optimization. Journal of Pharmaceutical Sciences 92(3): 529-535

Xie, Q.; Xiang, C.; Zhang, Y.; Yuan, Y.; Liu, M.; Nie, L.; Yao, S. 2002: In situ monitoring of gold-surface adsorption and acidic denaturation of human serum albumin by an isolation-capacitance-adopted electrochemical quartz crystal impedence system. Analytica Chimica Acta 464(1): 65-77

Hendrickx, L.; Hausner, M.; Wuertz, S. 2000: In situ monitoring of natural genetic transformation of Acinetobacter calcoaceticus BD413 in monoculture biofilms. Water Science and Technology 41(4-5): 155-158

Isidori, M.; Ferrara, M.; Lavorgna, M.; Nardelli, A.; Parrella, A. 2003: In situ monitoring of urban air in Southern Italy with the Tradescantia micronucleus bioassay and semipermeable membrane devices (SPMDs). Chemosphere 52(1): 121-126

Ito, T.; Harada, K.; Takada, G. 2001: In situ morphometric analysis of left and right ventricles in fetal rats: changes in ventricular volume, mass, wall thickness, and valvular size. Tohoku Journal of Experimental Medicine 193(1): 37-44

Olivier, J.C.; Djilani, M.; Fahmy, S.; Couet, W. 2001: In situ nasal absorption of midazolam in rats. International Journal of Pharmaceutics 213(1-2): 187-192

Mcminn, A.; Ashworth, C.; Ryan, K.G. 2000: In situ net primary productivity of an Antarctic fast ice bottom algal community. Aquatic Microbial Ecology 21(2): 177-185

Pereg-Gerk, L.; Sar, N.; Lipkin, Y. 2002: In situ nitrogen fixation associated with seagrasses in the Gulf of Elat (Red Sea). Aquatic Ecology 36(3): 387-394

Harada, K.; Sudo, Y.; Kono, N.; Ozaki, S.; Tsuneyama, K.; Gershwin, M.E.; Nakanuma, Y. 1999: In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis. Hepatology 30(1): 36-45

Ozaki, S.; Harada, K.; Sanzen, T.; Watanabe, K.; Tsui, W.; Nakanuma, Y. 1999: In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion. Hepatology 30(4): 914-919

Saito, K.; Ito, E.; Takakuwa, Y.; Tamura, M.; Kinjo, M. 2003: In situ observation of mobility and anchoring of PKCbetaI in plasma membrane. Febs Letters 541(1-3): 126-131

Rubens, P.; Snauwaert, J.; Heremans, K.; Stute, R. 1999: In situ observation of pressure-induced gelation of starches studied with FTIR in the diamond anvil cell. Carbohydrate Polymers 39(3): 231-235

Degraeve, P.; Rubens, P.; Lemay, P.; Heremans, K. 2002: In situ observation of pressure-induced increased thermostability of two beta-galactosidases with FT-IR spectroscopy in the diamond anvil cell. Enzyme and Microbial Technology 31(5): 673-684, 3 October

Wade, T.; Beattie, J.B. 1998: In situ observation of rennetting by electroacoustics. Milchwissenschaft 53(9): 490-494

Kaiser, H.; Kappen, L. 2000: In situ observation of stomatal movements and gas exchange of Aegopodium podagraria L. in the understorey. Journal of Experimental Botany 51(351): 1741-1749

Oms, C.; Gromaire, M.C.; Chebbo, G. 2003: In situ observation of the water-sediment interface in combined sewers, using endoscopy. Water Science and Technology: a Journal of the International Association on Water Pollution Research 47(4): 11-18

Woll, A.K. 2003: In situ observations of ovigerous Cancer pagurus Linnaeus, 1758 in Norwegian waters (Brachyura, Cancridae). Crustaceana 76(4): 469-478

Hudson, I.R.; Wigham, B.D. 2003: In situ observations of predatory feeding behaviour of the galatheid squat lobster Munida sarsi using a remotely operated vehicle. Journal of the: 463-464

Ferguson, R.E.; Sun, Y-Biao.; Mercier, P.; Brack, A.S.; Sykes, B.D.; Corrie, J.E.T.; Trentham, D.R.; Irving, M. 2003: In situ orientations of protein domains: Troponin C in skeletal muscle fibers. Molecular Cell 11(4): 865-874

Sayre, L.M.; Perry, G.; Harris, P.L.; Liu, Y.; Schubert, K.A.; Smith, M.A. 2000: In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals. Journal of Neurochemistry 74(1): 270-279

Trenerry, L.J.; Mcminn, A.; Ryan, K.G. 2002: In situ oxygen microelectrode measurements of bottom-ice algal production in McMurdo Sound, Antarctica. Polar Biology 25(1): 72-80

Tomori, H.; Shiraishi, M.; Muto, Y. 2000: In situ perfusion of the liver enhances the efficiency of retrovirus-mediated gene transfer to hepatocytes. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 32(1): 18-22

Tanaka, T.; Ito, T.; Furuta, M.; Eguchi, C.; Toda, H.; Wakabayashi-Takai, E.; Kaneko, K. 2002: In situ phage screening. a method for identification of subnanogram tissue components in situ. Journal of Biological Chemistry 277(33): 30382-30387

Kiyomiya, K.I.; Matsuo, S.; Kurebe, M. 2000: In situ photoaffinity labeling of proteasome with photoactive adriamycin analogue. Biochemical and Biophysical Research Communications 273(3): 928-932

Aoki, S.; Matsui, K.; Takata, T.; Kobayashi, M. 2003: In situ photoaffinity labeling of the target protein for lembehyne A, a neuronal differentiation inducer. FEBS Letters 544(1-3): 223-227

Paskins, L.; Brownie, J.; Bull, J. 1999: In situ polymerase chain reaction and cycling primed in situ amplification: Improvements and adaptations. Histochemistry and Cell Biology 111(5): 411-416

Sugimura; Sawabe; Ezura 2000: In situ polymerase chain reaction visualization of Vibrio halioticoli using alginate lyase gene alyVG2. Marine Biotechnology 2(1): 74-79

Shastri, V.Prasad.; Hildgen, P.; Langer, R. 2003: In situ pore formation in a polymer matrix by differential polymer degradation. Biomaterials 24(18): 3133-3137

Vidal, J.C.; Garcia, E.; Castillo, J.R. 1999: In situ preparation of a cholesterol biosensor: Entrapment of cholesterol oxidase in an overoxidized polypyrrole film electrodeposited in a flow system: Determination of total cholesterol in serum. Analytica Chimica Acta 385(1-3): 213-222

Andreana, P.R.; Xie, W.; Cheng, H.N.; Qiao, L.; Murphy, D.J.; Gu, Q.-M.; Wang, P.G. 2002: In situ preparation of beta-D-1-O-hydroxylamino carbohydrate polymers mediated by galactose oxidase. Organic Letters 4(11): 1863-1866

Korol'kov, V.I.; Platonova, G.A.; Azanova, V.V.; Tennikova, T.B.; Vlasov, G.P. 2000: In situ preparation of peptidylated polymers as ready-to-use adsorbents for rapid immunoaffinity chromatography. Letters in Peptide Science 7(1): 53-61

Mock, T. 2002: In situ primary production in young Antarctic sea ice. Hydrobiologia 470: 127-132, 15 February

Kalmbach, S.; Manz, W.; Bendinger, B.; Szewzyk, U. 2000: In situ probing reveals Aquabacterium commune as a widespread and highly abundant bacterial species in drinking water biofilms. Water Research 34(2): 575-581

Ling, C.; Sandor, M.; Fabry, Z. 2003: In situ processing and distribution of intracerebrally injected OVA in the CNS. Journal of Neuroimmunology 141(1-2): 90-98

Guidetti, P.; Wu, H.Q.; Schwarcz, R. 2000: In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum. Experimental Neurology 163(1): 123-130

Schroen, C.G.P.H.; Nierstrasz, V.A.; Bosma, R.; Kemperman, G.J.; Strubel, M.; Ooijkaas, L.P.; Beeftink, H.H.; Tramper, J. 2002: In situ product removal during enzymatic cephalexin synthesis by complexation. Enzyme and Microbial Technology 31(3): 264-273, 2 August

Dukler, A.; Freeman, A. 2001: In situ product removal of ketoses by immobilized 3-amino phenyl boronic acid: Effect of immobilization method on pH profile. Biotechnology and Bioengineering 75(1): 25-28

Fenhalls, G.; Wong, A.; Bezuidenhout, J.; van Helden, P.; Bardin, P.; Lukey, P.T. 2000: In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infection and Immunity 68(5): 2827-2836

Bergmann, K.; Neidhart, B. 2001: In situ propylation of ionic organotin and organolead species in water samples: Extraction and determination of the resulting tetraorganometallic compounds by gas chromatography-atomic absorption spectrometry. Journal of Separation Science 24(3): 221-225

Heisterkamp, M.; Adams, F.C. 1999: In situ propylation using sodium tetrapropylborate as a fast and simplified sample preparation for the speciation analysis of organolead compounds using GC-MIP-AES. Journal of Analytical Atomic Spectrometry 14(9): 1307-1311

Cubarsí, R.; Carrió, M.M.; Villaverde, A. 2001: In situ proteolytic digestion of inclusion body polypeptides occurs as a cascade process. Biochemical and Biophysical Research Communications 282(2): 436-441

Brecker, L.; Petschnigg, J.; Depiné, N.; Weber, Hörg.; Ribbons, D.W. 2003: In situ proton NMR analysis of alpha-alkynoate biotransformations. From 'invisible' substrates to detectable metabolites. European Journal of Biochemistry 270(7): 1393-1398

Smith, S.Jay.; Neugut, A.; Heitjan, D.; Forde, K.; Holt, P.; Santella, R.M.; Jiin-Chyuan, L.; Carney, W.; Ward, L.; Brandt-Rauf, P.W. 2003: In situ quantification of aberrant p53 in colorectal neoplasia. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 8(3-4): 311-332

Tik, N.; Bayraktar, E.; Mehmetoglu, U. 2001: In situ reactive extraction of lactic acid from fermentation media. Journal of Chemical Technology and Biotechnology 76(7): 764-768

Oliveira, A.C.; Rosa, M.F.; Teixeira, J.A.; Cabral, J.M.S.; Aires Barros, M.R. 1998: In situ recovery of ethanol by extraction and enzymatic esterification. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 63(4A): 1231-1238

Istok, J.D.; Amonette, J.E.; Cole, C.R.; Fruchter, J.S.; Humphrey, M.D.; Szecsody, J.E.; Teel, S.S.; Vermeul, V.R.; Williams, M.D.; Yabusaki, S.B. 1999: In situ redox manipulation by dithionite injection: Intermediate-scale laboratory experiments. Ground Water 37(6): 884-889

Su, C.; Puls, R.W. 2003: In situ remediation of arsenic in simulated groundwater using zerovalent iron: laboratory column tests on combined effects of phosphate and silicate. Environmental Science and Technology 37(11): 2582-2587

Vilensky, M.Y.; Berkowitz, B.; Warshawsky, A. 2002: In situ remediation of groundwater contaminated by heavy- and transition-metal ions by selective ion-exchange methods. Environmental Science and Technology 36(8): 1851-1855

Bykov, V.J.; Sheehan, J.M.; Hemminki, K.; Young, A.R. 1999: In situ repair of cyclobutane pyrimidine dimers and 6-4 photoproducts in human skin exposed to solar simulating radiation. Journal of Investigative Dermatology 112(3): 326-331

Zhao, C.; Snellman, E.; Jansen, C.T.; Hemminki, K. 2002: In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients. International Journal of Cancer 98(3): 331-334

Hayes, P.D.; Nasim, A.; London, N.J.; Sayers, R.D.; Barrie, W.W.; Bell, P.R.; Naylor, A.R. 1999: In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: The Leicester experience (1992 to 1998). Journal of Vascular Surgery 30(1): 92-98

Ting, A.C.; Gleave, M.E.; Hsiang, Y.N. 1999: In situ replacement of the aorta in a contaminated field with the infrarenal inferior vena cava. Journal of Vascular Surgery 30(2): 363-366

Poindexter, J.S.; Pujara, K.P.; Staley, J.T. 2000: In situ reproductive rate of freshwater Caulobacter spp. Applied and Environmental Microbiology 66(9): 4105-4111

Frieg, B.; Alexander, W.R.; Dollinger, H.; Buehler, C.; Haag, P.; Moeri, A.; Ota, K. 1998: In situ resin impregnation for investigating radionuclide retardation in fractured repository host rocks. Journal of Contaminant Hydrology 35(1-3): 115-130

Yoong, E.T.; Lant, P.A.; Greenfield, P.F. 2000: In situ respirometry in an SBR treating wastewater with high phenol concentrations. Water Research 34(1): 239-245

Menschikowski, M.; Vogel, M.; Eckey, R.; Dinnebier, G.; Jaross, W. 2001: In situ reverse transcriptase-nested polymerase chain reaction to identify intracellular nucleic acids without the necessity of DNAse pretreatment and hybridisation. Analytical Cellular Pathology: the Journal of the European Society for Analytical Cellular Pathology 22(3): 151-158

Politz, J.C.; Singer, R.H. 1999: In situ reverse transcription for detection of hybridization between oligonucleotides and their intracellular targets. Methods 18(3): 281-285

Sinigalliano, C.D.; Kuhn, D.N.; Jones, R.D.; Guerrero, M.A. 2001: In situ reverse transcription to detect the cbbL gene and visualize RuBisCO in chemoautotrophic nitrifying bacteria. Letters in Applied Microbiology 32(6): 388-393

Lange, M.; Tolker-Nielsen, T.; Molin, S.; Ahring, B.K. 2000: In situ reverse transcription-PCR for monitoring gene expression in individual Methanosarcina mazei S-6 cells. Applied and Environmental Microbiology 66(5): 1796-1800

Krams, M.; Peters, J.; Boeckel, F.; Raether, A.; Ambros, P.F.; Parwaresch, R.; Harms, D. 2000: In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors. Virchows Archiv: An International Journal of Pathology 437(3): 234-240

Yang, C.M. J.; Cheng, Y.H.; Lin, Y.A.; Lee, C.F. 1999: In situ ruminal degradation characteristics of dry matter and cell wall components in alfalfa, bermuda, and pangola hays. Journal of the Agricultural Association of China 1999(185): 81-100

Ralph, P.J.; Gademann, R.; Dennison, W.C. 1998: In situ seagrass photosynthesis measured using a submersible, pulse-amplitude modulated fluorometer. Marine Biology (Berlin) 132(3): 367-373

Turczyn, R.; Weiss, P.; Lapkowski, M.; Daculsi, G. 2000: In situ self hardening bioactive composite for bone and dental surgery. Journal of Biomaterials Science. Polymer Edition 11(2): 217-223

Leis, J.M.; Carson-Ewart, B.M. 2002: In situ settlement behaviour of damselfish (Pomacentridae) larvae. Journal of Fish Biology 61(2): 325-346

Nielsen, H. 2001: In situ solid phase extraction of phospholipids from heat-coagulated egg yolk by organic solvents. Lebensmittel-Wissenschaft and Technologie 34(8): 526-532

Ferguson, B.G.; Cleary, J.L. 2001: In situ source level and source position estimates of biological transient signals produced by snapping shrimp in an underwater environment. Journal of the Acoustical Society of America 109(6): 3031-3037

Fujiwara, Y.; Tsukahara, J.; Hashimoto, J.; Fujikura, K. 1998: In situ spawning of a deep-sea vesicomyid clam: Evidence for an environmental cue. Deep-Sea Research Part I Oceanographic Research Papers 45(11): 1881-1889

Kilic, M.; Seu, P.; Stribling, R.J.; Ghalib, R.; Goss, J.A. 2001: In situ splitting of the cadaveric liver for two adult recipients. Transplantation 72(11): 1853-1858

Tschibrikova, E.V.; Snigirevsky, S., M.; Olly, V.A. 1999: In situ spores of some Frasnian fossil plants from the Northern Timan (Russia). Acta Palaeobotanica Suppl (2): 67-71

Otvos, L.; Pease, A.M.; Bokonyi, K.; Giles-Davis, W.; Rogers, M.E.; Hintz, P.A.; Hoffmann, R.; Ertl, H.C. 2000: In situ stimulation of a T helper cell hybridoma with a cellulose-bound peptide antigen. Journal of Immunological Methods 233(1-2): 95-105

Takai, S.; Dohno, H.; Watanabe, Y.; Yoshino, N.; Ogura, T.; Hirasawa, Y. 2002: In situ strain and stress of nerve conduction blocking in the brachial plexus. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 20(6): 1311-1314

Nuovo, G.J. 2000: In situ strand displacement amplification: an improved technique for the detection of low copy nucleic acids. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 9(4): 195-202

Vacca Smith, A.M.; Bowen, W.H. 2000: In situ studies of pellicle formation on hydroxyapatite discs. Archives of Oral Biology 45(4): 277-291

Styrishave, B.; Aagaard, A.; Andersen, O. 1999: In situ studies on physiology and behaviour in two colour forms of the shore crab Carcinus maenas in relation to season. Marine Ecology Progress Series 189: 221-231

Forster, S.; Glud, R.N.; Gundersen, J.K.; Huettel, M. 1999: In situ study of bromide tracer and oxygen flux in coastal sediments. Estuarine Coastal and Shelf Science 49(6): 813-827

Kwon, Y.M.; Baudys, M.; Knutson, K.; Kim, S.W. 2001: In situ study of insulin aggregation induced by water-organic solvent interface. Pharmaceutical Research (New York) 18(12): 1754-1759

Fukui, M.; Suh, J.I.; Urushigawa, Y. 2000: In situ substrates for sulfidogens and methanogens in municipal anaerobic sewage digesters with different levels of sulfate. Water Research 34(5): 1515-1524

Piazzi, L.; Acunto, S.; Cinelli, F. 1999: In situ survival and development of Posidonia oceanica (L.) Delile seedlings. Aquatic Botany 63(2): 103-112

Lachance, S.; Berube, P.; Lemieux, M. 2000: In situ survival and growth of three brook trout (Salvelinus fontinalis) strains subjected to acid conditions of anthropogenic origin at the egg and fingerling stages. Canadian Journal of Fisheries and Aquatic Sciences 57(8): 1562-1573

Torgersen, T.; Kaartvedt, S. 2001: In situ swimming behaviour of individual mesopelagic fish studied by split-beam echo target tracking. ICES Journal of: 346-354

Hirai, N.; Sonobe, S.; Hayashi, T. 1998: In situ synthesis of beta-glucan microfibrils on tobacco plasma membrane sheets. Proceedings of the National Academy of Sciences of the United States of America 95(25): 15102-15106

Warner, D.M.; Rudstam, L.G.; Klumb, R.A. 2002: In situ target strength of alewives in freshwater. Transactions of the American Fisheries Society ch; 131(2): 212-223

Gauthier, S.; Rose, G., A. 2002: In situ target strength studies on Atlantic redfish (Sebastes spp.). ICES Journal of Marine Science 59(4): 805-815

Dejmek, A.; Yahata, N.; Ohyashiki, K.; Ebihara, Y.; Kakihana, M.; Hirano, T.; Kawate, N.; Kato, H. 2001: In situ telomerase activity in pleural effusions: A promising marker for malignancy. Diagnostic Cytopathology 24(1): 11-15

Lu, J.-Ping; Zhu, S.; Song, B.; Mao, J.; Lu, S.; Su, Y.; Zhang, W. 1999: In situ telomeric repeat amplification protocol (TRAP) detecting telomerase activity in human hepatocellular carcinoma. Acta Histochemica et Cytochemica 32(6): 477-480

Graça, M.A.S.; Rodrígues-Capítulo, A.; Ocón, C.; Gómez, N. 2002: In situ tests for water quality assessment: a case study in Pampean rivers. Water Research 36(16): 4033-4040

Skinner, P.J.; Haase, A.T. 2002: In situ tetramer staining. Journal of Immunological Methods 268(1): 29-34

Brabb, T.; von Dassow, P.; Ordonez, N.; Schnabel, B.; Duke, B.; Goverman, J. 2000: In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. Journal of Experimental Medicine 192(6): 871-880

Baudo, R.; Rossi, D.; Beltrami, M. 2001: In situ toxicity testing of Lake Orta sediments. Journal of Limnology 60(2): 277-284

Zhang, Z.; Yin, L.; Zhang, Y.; Zhao, F. 2002: In situ transduction of cytosine deaminase gene followed by systemic use of 5-fluorocytosine inhibits tumor growth and metastasis in orthotopic prostate cancer mouse models. Chinese Medical Journal 115(2): 227-231

Barbosa, Fernando,. Jr.;; De-Souza, Samuel-Simiao; Krug, Francisco, J. 2002: In situ trapping of selenium hydride in rhodium-coated tungsten coil electrothermal atomic absorption spectrometry. Journal of Analytical Atomic Spectrometry 17(4): 382-388

Egilmez, N.K.; Jong, Y.S.; Sabel, M.S.; Jacob, J.S.; Mathiowitz, E.; Bankert, R.B. 2000: In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Research 60(14): 3832-3837

Devries, C.R.; Wang, F. 2003: In situ two-dimensional high-resolution profiling of sulfide in sediment interstitial waters. Environmental Science and Technology 37(4): 792-797

Stefani, M.M.A.; Martelli, C.M.T.; Gillis, T.P.; Krahenbuhl, J.L. 2003: In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression. Journal of Infectious Diseases 188(7): 1024-1031

Neville, M.E.; Robb, R.J.; Popescu, M.C. 2001: In situ vaccination against a non-immunogenic tumour using intratumoural injections of liposomal interleukin 2. Cytokine 16(6): 239-250

Appell, R.A. 2000: In situ vaginal wall sling. Urology 56(3): 499-503

Correa, C.H.; Mattos, A.L.; Ferrari, A.N. 2001: In situ variation of cervical mucus pH during exposure to atmospheric air. Brazilian Journal of Medical and Biological Research 34(6): 767-770

Lunven, Michel [author, Reprint-Author]; Gentien, P.; Kononen, K.; Le-Galla, E.; Danielou, M.M. 2003: In situ video and diffraction analysis of marine particles. Estuarine Coastal and Shelf Science 57(5-6): 1127-1137

Nishii, W.; Shoda, T.; Matsumoto, N.; Nakamura, T.; Kudo, Y.; Takahashi, K. 2002: In situ visualization of caspase-1-like activity associated with promotion of hippocampal cell death. FEBS Letters 518(1-3): 149-153

Mandell, J.W.; Hussaini, I.M.; Zecevic, M.; Weber, M.J.; VandenBerg, S.R. 1998: In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. American Journal of Pathology 153(5): 1411-1423

Fincan, M.D.jmek, P. 2002: In situ visualization of the effect of a pulsed electric field on plant tissue. Journal of food engineering 55(3): 223-230

Tsujii, E.; Tanaka, H.; Oyamada, M.; Fujita, K.; Hamamoto, T.; Takamatsu, T. 2003: In situ visualization of the intracellular Ca2+ dynamics at the border of the acute myocardial infarct. Molecular and Cellular Biochemistry 248(1-2): 135-139

Katsumi, S.; Kobayashi, N.; Imoto, K.; Nakagawa, A.; Yamashina, Y.; Muramatsu, T.; Shirai, T.; Miyagawa, S.; Sugiura, S.; Hanaoka, F.; Matsunaga, T.; Nikaido, O.; Mori, T. 2001: In situ visualization of ultraviolet-light-induced DNA damage repair in locally irradiated human fibroblasts. Journal of Investigative Dermatology 117(5): 1156-1161

Freemont, A.J.; Byers, R.J.; Taiwo, Y.O.; Hoyland, J.A. 1999: In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage. Annals of the Rheumatic Diseases 58(6): 357-365

Mungall, B.A.; Pollitt, C.C. 2001: In situ zymography: Topographical considerations. Journal of Biochemical and Biophysical Methods 47(3): 169-176

Tritt-Goc, J.; Kowalczuk, J. 2002: In situ, real time observation of the disintegration of paracetamol tablets in aqueous solution by magnetic resonance imaging. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 15(4): 341-346

Sanna, E.; Woodall, C.J.; Watt, N.J.; Clarke, C.J.; Pittau, M.; Leoni, A.; Nieddu, A.M. 2000: In situ-PCR for the detection of Mycobacterium paratuberculosis DNA in paraffin-embedded tissues. European Journal of Histochemistry: Ejh 44(2): 179-184

Miosge, N.; Kluge, J.-G.A.; Studzinski, A.; Zelent, C.; Bode, C.; Sprysch, P.; Burgeson, R.E.; Herken, R. 2002: In situ-RT-PCR and immunohistochemistry for the localisation of the mRNA of the alpha 3 chain of laminin and laminin-5 during human organogenesis. Anatomy and Embryology 205(5-6): 355-363

Miyazaki, S.; Aoyama, H.; Kawasaki, N.; Kubo, W.; Attwood, D. 1999: In situ-gelling gellan formulations as vehicles for oral drug delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society 60(2-3): 287-295

Pinna, G.; Dong, E.; Matsumoto, K.; Costa, E.; Guidotti, A. 2003: In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proceedings of the National Academy of Sciences of the United States of America 100(4): 2035-2040

DiPolo, R.; Berberián, G.; Beaugé, L. 2000: In squid nerves intracellular Mg(2+) promotes deactivation of the ATP-upregulated Na(+)/Ca(2+) exchanger. American Journal of Physiology. Cell Physiology 279(5): C1631-C1639

Gabbay, E.; Haydn Walters, E.; Orsida, B.; Whitford, H.; Ward, C.; Kotsimbos, T.C.; Snell, G.I.; Williams, T.J. 1999: In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS. American Journal of Respiratory and Critical Care Medicine 160(6): 2093-2099

Hirata, M.; Katsumata, K.; Endo, K.; Fukushima, N.; Ohkawa, H.; Fukagawa, M. 2003: In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 18(9): 1770-1776

Williamson, R.T.; McDonald, L.A.; Barbieri, L.R.; Carter, G.T. 2002: In support of the original medermycin/lactoquinomycin a structure. Organic Letters 4(26): 4659-4662

Ito, Y.; Kuhara, S.; Tashiro, K. 2001: In synergy with noggin and follistatin, Xenopus nodal-related gene induces sonic hedgehog on notochord and floor plate. Biochemical and Biophysical Research Communications 281(3): 714-719

Dores, R.M.; Lee, J.; Sollars, C.; Danielson, P.; Lihrmann, I.; Vallarino, M.; Vaudry, H. 2000: In the african lungfish Met-enkephalin and leu-enkephalin are derived from separate genes: cloning of a proenkephalin cDNA. Neuroendocrinology 72(4): 224-230

Bostrom, B.A. 2002: In the Michigan Court of Appeals: In the Matter of AMB, a Minor. Issues in Law and Medicine 18(1): 45-55

Bostrom, B.A. 2002: In the Michigan Court of Appeals: People vs. Jack Kevorkian. Issues in Law and Medicine 18(1): 57-64

Jankovic, D.; Kullberg, M.C.; Hieny, S.; Caspar, P.; Collazo, C.M.; Sher, A. 2002: In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 16(3): 429-439

Callebaut, M.; Van Nueten, E.; Bortier, H.; Harrisson, F. 2002: In the absence of Rauber's sickle material, no blood islands are formed in the avian blastoderm. Journal of Morphology 253(2): 132-147

Adler, H.; Beland, J.L.; Del-Pan, N.C.; Kobzik, L.; Sobel, R.A.; Rimm, I.J. 1999: In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. Journal of Neuroimmunology 93(1-2): 208-213

Rathmell, J.C.; Vander Heiden, M.G.; Harris, M.H.; Frauwirth, K.A.; Thompson, C.B. 2000: In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Molecular Cell 6(3): 683-692

Soubannier, V.; Vaillier, J.; Paumard, P.; Coulary, B.; Schaeffer, J.; Velours, J. 2002: In the absence of the first membrane-spanning segment of subunit 4(b), the yeast ATP synthase is functional but does not dimerize or oligomerize. Journal of Biological Chemistry 277(12): 10739-10745

Hamilton, G.R.; Baskett, T.F. 2000: In the arms of Morpheus the development of morphine for postoperative pain relief. Canadian Journal of Anaesthesia 47(4): 367-374

Sugden, B. 2002: In the beginning: A viral origin exploits the cell. Trends in Biochemical Sciences 27(1): 1-3

Jewell, N.A.; Mansky, L.M. 2000: In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. Journal of General Virology 81(Part 8): 1889-1899

Denkers, E.Y.; Kim, L.; Butcher, B.A. 2003: In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection. Cellular Microbiology 5(2): 75-83

Petty, T.L.; Petty, T.L. 2001: In the cards was ARDS: how we discovered the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 163(3 Pt 1): 602-603

Shi, Y.; Gaestel, M. 2002: In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biological Chemistry 383(10): 1519-1536

Zimmermann, K.C.; Pinkoski, M.J. 2001: In the company of killers. Trends in Molecular Medicine 7(5): 195-197

Jones, R.B. 2002: In the country of the blind?. Journal of Epidemiology and Community Health 56(12): 885-887

Choumenkovitch, S.F.; Selhub, J.; Bagley, P.J.; Maeda, N.; Nadeau, M.R.; Smith, D.E.; Choi, S.-W. 2002: In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. Journal of Nutrition 132(8): 2157-2160

Vainio, M.; Mäenpää, J.; Riutta, A.; Ylitalo, P.; Ala-Fossi, S.L.; Tuimala, R. 1999: In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies. Acta Obstetricia et Gynecologica Scandinavica 78(2): 82-88

Jenny, N.S.; Tracy, R.P.; Ogg, M.S.; Luong, L.Ahn.; Kuller, L.H.; Arnold, A.M.; Sharrett, A.Richey.; Humphries, S.E. 2002: In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arteriosclerosis Thrombosis and Vascular Biology 22(12): 2066-2071

Riskin, A.; Kugelman, A.; Kuglman, A.; Abend-Weinger, M.; Green, M.; Hemo, M.; Bader, D. 2003: In the eye of the beholder: How accurate is clinical estimation of jaundice in newborns?. Acta Paediatrica 92(5): 574-576

Saraiva, L.M.; da Costa, P.N.; Conte, C.; Xavier, A.V.; LeGall, J. 2001: In the facultative sulphate/nitrate reducer Desulfovibrio desulfuricans ATCC 27774, the nine-haem cytochrome c is part of a membrane-bound redox complex mainly expressed in sulphate-grown cells. Biochimica et Biophysica Acta 1520(1): 63-70

Kornet, L.; Hoeks, A.P.; Lambregts, J.; Reneman, R.S. 1999: In the femoral artery bifurcation, differences in mean wall shear stress within subjects are associated with different intima-media thicknesses. Arteriosclerosis Thrombosis and Vascular Biology 19(12): 2933-2939

Sharma, V.K.; Chandrashekaran, M.K.; Singaravel, M.; Subbaraj, R. 1999: In the field mouse Mus booduga melatonin phase response curves (PRCs) have a different time course and wave form relative to light PRC. Journal of Pineal Research 26(3): 153-157

Renaud-Young, M.; Gallin, W.J. 2002: In the first extracellular domain of E-cadherin, heterophilic interactions, but not the conserved His-Ala-Val motif, are required for adhesion. Journal of Biological Chemistry 277(42): 39609-39616

Maier, E. 1999: In the footsteps of Lantzius-Beninga - The weight of peristome characters of mosses (Bryophyta). Stuttgarter Beitraege zur Naturkunde Serie A (Biologie) 1999(591): 1-13

Bardin, L.; Tarayre, J.P.; Koek, W.; Colpaert, F.C. 2001: In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. European Journal of Pharmacology 421(2): 109-114

Barnard, D. 2002: In the high court of South Africa, case no. 4138/98: the global politics of access to low-cost AIDS drugs in poor countries. Kennedy Institute of Ethics Journal 12(2): 159-174

Blanchard, N.; Di Bartolo, V.; Hivroz, C. 2002: In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern. Immunity 17(4): 389-399

Johnson, D.F. 2002: In the lab with George: 20 years without plumbing or wiring. Appetite 38(2): 136-139

Leroy, C.; Roch, C.; Koning, E.; Namer, I.J.; Nehlig, A. 2003: In the lithium-pilocarpine model of epilepsy, brain lesions are not linked to changes in blood-brain barrier permeability: An autoradiographic study in adult and developing rats. Experimental Neurology 182(2): 361-372

Mitruka, S.N.; Won, A.; Mccurry, K.R.; Zeevi, A.; Mckaveney, T.; Venkataramanan, R.; Iacono, A.; Griffith, B.P.; Burckart, G.J. 2000: In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 19(10): 969-975

Reale, E.; Groos, S.; Luciano, L.; Eckardt, C.; Eckardt, U. 2001: In the mammalian eye type VI collagen tetramers form three morphologically different aggregates. Matrix Biology: Journal of the International Society for Matrix Biology 20(1): 37-51

Gabrielyan, E.S.; Amroyan, E.A.; Zakaryan, A.A.; Osipyan, L.L.; Pogosyan, U.G. 2003: In the matter of regulation of biologically active supplements in Republic of Armenia. Voprosy Pitaniia 62(1): 27-29

Costello, R.B.; Coates, P. 2001: In the midst of confusion lies opportunity: fostering quality science in dietary supplement research. Journal of the American College of Nutrition 20(1): 21-25

Moore, D.; Chiu, S.-Wai; Umar, M.H.; Sanchez, C. 1998: In the midst of death we are in life: Further advances in the study of higher fungi. Botanical Journal of Scotland 50(2): 121-135

Hanski, I. 2002: In the midst of ecology, conservation, and competing interests in the society. Annales Zoologici Fennici 39(3): 183-186

Zeretzke, S.; Berking, S. 2002: In the multiheaded strain (mh-1) of Hydra magnipapillata the ectodermal epithelial cells are responsible for the formation of additional heads and the endodermal epithelial cells for the reduced ability to regenerate a foot. Development Growth and Differentiation 44(1): 85-93

Jobling, M.A. 2001: In the name of the father: surnames and genetics. Trends in Genetics: Tig 17(6): 353-357

Amoroso, S.; Gioielli, A.; Cataldi, M.; Di Renzo, G.; Annunziato, L. 1999: In the neuronal cell line SH-SY5Y, oxidative stress-induced free radical overproduction causes cell death without any participation of intracellular Ca(2+) increase. Biochimica et Biophysica Acta 1452(2): 151-160

De Conto, F.; Razin, S.V.; Geraud, G.; Arcangeletti, C.; Scherrer, K. 1999: In the nucleus and cytoplasm of chicken erythroleukemic cells, prosomes containing the p23K subunit are found in centers of globin (pre-)mRNA processing and accumulation. Experimental Cell Research 250(2): 569-575

Brisson, J.; Bouchard, A. 2003: In the past-two centuries, human activities have caused major changes in the tree species composition of southern Quebec, Canada. Ecoscience 10(2): 236-246

Grønlien, H.K.; Berg, T.; Løvlie, A.M. 2002: In the polymorphic ciliate Tetrahymena vorax, the non-selective phagocytosis seen in microstomes changes to a highly selective process in macrostomes. Journal of Experimental Biology 205(Part 14): 2089-2097

Chatterjee, M.; Hönemann, D.; Lentzsch, S.; Bommert, K.; Sers, C.; Herrmann, P.; Mathas, S.; Dörken, B.; Bargou, R.C. 2002: In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway. Blood 100(9): 3311-3318

De Meester, J.; Persijn, G.G.; Claas, F.H.; Frei, U. 2000: In the queue for a cadaver donor kidney transplant: new rules and concepts in the Eurotransplant International Foundation. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 15(3): 333-338

Rénéric, J-Philippe.; Bouvard, M.; Stinus, L. 2002: In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs. Behavioural Brain Research 136(2): 521-532

Masson-Bessière, C.; Sebbag, M.; Durieux, J.J.; Nogueira, L.; Vincent, C.; Girbal-Neuhauser, E.; Durroux, R.; Cantagrel, A.; Serre, G. 2000: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clinical and Experimental Immunology 119(3): 544-552

Diederich, S.; Grossmann, C.; Hanke, B.; Quinkler, M.; Herrmann, M.; Bähr, V.; Oelkers, W. 2000: In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. European Journal of Endocrinology 142(2): 200-207

Purviance, J.D.; Prack, A.E.; Barbaro, B.A.; Bullock, P.A. 2001: In the simian virus 40 in vitro replication system, start site selection by the polymerase alpha-primase complex is not significantly altered by changes in the concentration of ribonucleotides. Journal of Virology 75(14): 6392-6401

Parmley, W.W. 2003: In the statin era, how important are intense lifestyle changes?. Journal of the American College of Cardiology 41(2): 273-274

Walker, J.; Holloway, I.; Sofaer, B. 1999: In the system: The lived experience of chronic back pain from the perspectives of those seeking help from pain clinics. Pain. Supplement 80(3): 621-628

Dickstein, K. 2002: In the treatment of heart failure, faster may not always be better. European Heart Journal 23(16): 1239-1241

Commons, K.G.; Kow, L.M.; Milner, T.A.; Pfaff, D.W. 1999: In the ventromedial nucleus of the rat hypothalamus, GABA-immunolabeled neurons are abundant and are innervated by both enkephalin- and GABA-immunolabeled axon terminals. Brain Research 816(1): 58-67

Ten Eyck, T.A.; Deseran, F.A. 2001: In the words of experts: The interpretive process of the food irradiation debate. International Journal of Food Science and Technology 36(8): 821-831

Burchett, S.A. 2003: In through the out door: Nuclear localization of the regulators of G protein signaling. Journal of Neurochemistry 87(3): 551-559

Bimonte, H.A.; Hyde, L.A.; Hoplight, B.J.; Denenberg, V.H. 2000: In two species, females exhibit superior working memory and inferior reference memory on the water radial-arm maze. Physiology and Behavior 70(3-4): 311-317

Rosborough, T.K. 1998: In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone. Pharmacotherapy 18(6): 1217-1223

Zimmermann, K.; Gibrat, J.F. 1998: In unison: regularization of protein secondary structure predictions that makes use of multiple sequence alignments. Protein Engineering 11(10): 861-865

Perera, F.; Hemminki, K.; Jedrychowski, W.; Whyatt, R.; Campbell, U.; Hsu, Y.; Santella, R.; Albertini, R.; O'Neill, J.P. 2002: In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 11(10 Part 1): 1134-1137

Randall, S.; Hannigan, J.H. 1999: In utero alcohol and postnatal methylphenidate: Locomotion and dopamine receptors. Neurotoxicology and Teratology 21(5): 587-593

Nathanson, S.; Moreau, E.; Merlet-Benichou, C.; Gilbert, T. 2000: In utero and in vitro exposure to beta-lactams impair kidney development in the rat. Journal of the American Society of Nephrology: Jasn 11(5): 874-884

Hamm, J.T.; Sparrow, B.R.; Wolf, D.; Birnbaum, L.S. 2000: In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal development of seminal vesicle epithelium. Toxicological Sciences: An Official Journal of the Society of Toxicology 54(2): 424-430

Kuchiiwa, S.; Cheng, S.Bin.; Nagatomo, I.; Akasaki, Y.; Uchida, M.; Tominaga, M.; Hashiguchi, W.; Kuchiiwa, T. 2002: In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases serotonin-immunoreactive neurons in raphe nuclei of male mouse offspring. Neuroscience Letters 317(2): 73-76

Ko, K.; Theobald, H.M.; Peterson, R.E. 2002: In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the C57BL/6J mouse prostate: lobe-specific effects on branching morphogenesis. Toxicological Sciences: An Official Journal of the Society of Toxicology 70(2): 227-237

Thuett, K.A.; Roots, E.H.; Mitchell, L.P.; Gentles, B.Angella.; Anderson, T.A.; Smith, E.E. 2002: In utero and lactational exposure to ammonium perchlorate in drinking water: effects on developing deer mice at postnatal day 21. Journal of Toxicology and Environmental Health. Part a 65(15): 1061-1076

Lewis, B.C.; Hudgins, S.; Lewis, A.; Schorr, K.; Sommer, R.; Peterson, R.E.; Flaws, J.A.; Furth, P.A. 2001: In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat. Toxicological Sciences: An Official Journal of the Society of Toxicology 62(1): 46-53

Annesi-Maesano, I.; Moreau, D.; Strachan, D. 2001: In utero and perinatal complications preceding asthma. Allergy 56(6): 491-497

Oliveira, M.J.; Pereira, A.S.; Castelo Branco, N.A.; Grande, N.R.; Aguas, A.P. 2001: In utero and postnatal exposure of Wistar rats to low frequency/high intensity noise depletes the tracheal epithelium of ciliated cells. Lung 179(4): 225-232

Jones, L.B.; Stanwood, G.D.; Reinoso, B.S.; Washington, R.A.; Wang, H.Y.; Friedman, E.; Levitt, P. 2000: In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 20(12): 4606-4614

Dunn, K.J.; Incao, A.; Watkins-Chow, D.; Li, Y.; Pavan, W.J. 2001: In utero complementation of a neural crest-derived melanocyte defect using cell directed gene transfer. Genesis 30(2): 70-76

Garcia, A.M.; Morgan, W.M.; Bruner, J.P. 1998: In utero decompression of a cystic grade IV sacrococcygeal teratoma. Fetal Diagnosis and Therapy 13(5): 305-308

Blackall, D.P.; Liles, L.H.; Talati, A.J. 2002: In utero development of a warm-reactive autoantibody in a severely jaundiced neonate. Transfusion 42(1): 44-47

Löwenstein, L.; Solt, I.; Talmon, R.; Pery, M.; Suhov, P.; Drugan, A. 2003: In utero diagnosis of bladder perforation with urinary ascites. A case report. Fetal Diagnosis and Therapy 18(3): 179-182

Quintero, R.A.; Morales, W.J.; Gilbert-Barness, E.; Claus, J.; Bornick, P.W.; Allen, M.H.; Ackerman, J.; Koussef, B. 2000: In utero diagnosis of trichothiodystrophy by endoscopically-guided fetal eyebrow biopsy. Fetal Diagnosis and Therapy 15(3): 152-155

Ramachandran, V.; Perez, A.; Chen, J.; Senthil, D.; Schenker, S.; Henderson, G.I. 2001: In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: A potential role for 4-hydroxynonenal. Alcoholism Clinical and Experimental Research 25(6): 862-871

Tajuddin, N.F.; Druse, M.J. 1999: In utero ethanol exposure decreased the density of serotonin neurons. Maternal ipsapirone treatment exerted a protective effect. Brain Research. Developmental Brain Research 117(1): 91-97

Sylvester, L.; Kapron, C.M.; Smith, C. 2000: In utero ethanol exposure decreases rapid eye movement sleep in female Sprague-Dawley rat offspring. Neuroscience Letters 289(1): 13-16

Druse, M.J.; Hao, H.L.; Eriksen, J.L. 1999: In utero ethanol exposure increases proenkephalin, a precursor of a neuropeptide that is inhibitory to neuronal growth. Alcoholism Clinical and Experimental Research 23(9): 1519-1527

Fujita, Y.; Satoh, S.; Nakayama, H.; Taguchi, T.; Suita, S.; Nakano, H. 2001: In utero evaluation and the long-term prognosis of living infants with cystic hygroma. Fetal Diagnosis and Therapy 16(6): 402-406

Loertscher, J.A.; Lin, T-Min.; Peterson, R.E.; Allen-Hoffmann, B.Lynn. 2002: In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicological Sciences: An Official Journal of the Society of Toxicology 68(2): 465-472

You, L.; Brenneman, K.A.; Heck, H. 1999: In utero exposure to antiandrogens alters the responsiveness of the prostate to p,p'-DDE in adult rats and may induce prostatic inflammation. Toxicology and Applied Pharmacology 161(3): 258-266

Hinoue, A.; Fushiki, S.; Nishimura, Y.; Shiota, K. 2001: In utero exposure to brief hyperthermia interferes with the production and migration of neocortical neurons and induces apoptotic neuronal death in the fetal mouse brain. Brain Research. Developmental Brain Research 132(1): 59-67

van Driel, D.; Wesseling, J.; Sauer, P.J.; van Der Veer, E.; Touwen, B.C.; Smrkovsky, M. 2001: In utero exposure to coumarins and cognition at 8 to 14 years old. Pediatrics 107(1): 123-129

Dalgaard, M.; Pilegaard, K.; Ladefoged, O. 2002: In utero exposure to diethylstilboestrol or 4-n-nonylphenol in rats: Number of sertoli cells, diameter and length of seminiferous tubules estimated by stereological methods. Pharmacology and Toxicology 90(2): 59-65

Prévot, A.; Martini, S.; Guignard, J-Pierre. 2002: In utero exposure to immunosuppressive drugs. Biology of the Neonate 81(2): 73-81

Tendron, A.; Gouyon, J-B.; Decramer, S. 2002: In utero exposure to immunosuppressive drugs: Experimental and clinical studies. Pediatric Nephrology 17(2): 121-130

Annesi-Maesano, I.; Pollitt, R.; King, G.; Bousquet, J.; Hellier, G.; Sahuquillo, J.; Huel, G. 2003: In utero exposure to lead and cord blood total IgE. Is there a connection?. Allergy 58(7): 589-594

Watanabe, C.; Yin, K.; Kasanuma, Y.; Satoh, H. 1999: In utero exposure to methylmercury and Se deficiency converge on the neurobehavioral outcome in mice. Neurotoxicology and Teratology 21(1): 83-88

Lauder, J.M.; Liu, J.; Grayson, D.R. 2000: In utero exposure to serotonergic drugs alters neonatal expression of 5-HT(1A) receptor transcripts: a quantitative RT-PCR study. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 18(2-3): 171-176

Wichterle, H.; Turnbull, D.H.; Nery, S.; Fishell, G.; Alvarez-Buylla, A. 2001: In utero fate mapping reveals distinct migratory pathways and fates of neurons born in the mammalian basal forebrain. Development 128(19): 3759-3771

Heckel, S.; Favre, R.; Flori, J.; Koenig, M.; Mandel, J.; Gasser, B.; Chaigne, D. 1999: In utero fetal muscle biopsy: a precious aid for the prenatal diagnosis of Duchenne muscular dystrophy. Fetal Diagnosis and Therapy 14(3): 127-132

Bennett, M.; Galan, H.; Owens, G.; Dewey, R.; Banks, R.; Hobbins, J.; Accurso, F.; Schaack, J. 2001: In utero gene delivery by intraamniotic injection of a retroviral vector producer cell line in a nonhuman primate model. Human Gene Therapy 12(15): 1857-1865

Martínez-Serrano, A.; Olsson, M.; Gates, M.A.; Björklund, A. 1998: In utero gene transfer reveals survival effects of nerve growth factor on rat brain cholinergic neurones during development. European Journal of Neuroscience 10(1): 263-271

Kozlowski, R.; Bouffler, S.D.; Haines, J.W.; Harrison, J.D.; Cox, R. 2001: In utero haemopoietic sensitivity to alpha, beta or X-irradiation in CBA/H mice. International Journal of Radiation Biology 77(7): 805-815

Hayashi, S.; Flake, A.W. 2001: In utero hematopoietic stem cell therapy. Yonsei Medical Journal 42(6): 615-629

Surbek, D.V.; Gratwohl, A.; Holzgreve, W. 1999: In utero hematopoietic stem cell transfer: Current status and future strategies. European Journal of Obstetrics Gynecology and Reproductive Biology 85(1): 109-115

Shields, L.E.; Gaur, L.K.; Gough, M.; Potter, J.; Sieverkropp, A.; Andrews, R.G. 2003: In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 21(3): 304-314

Flake, A.W.; Zanjani, E.D. 1999: In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 94(7): 2179-2191

Meertens, L.; Zhao, Y.; Rosic-Kablar, S.; Li, L.; Chan, K.; Dobson, H.; Gartley, C.; Lutzko, C.; Hopwood, J.; Kohn, D.; Kruth, S.; Hough, M.R.; Dubé, I.D. 2002: In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression. Human Gene Therapy 13(15): 1809-1820

Lasky, L.C.; Lane, T.A.; Miller, J.P.; Lindgren, B.; Patterson, H.A.; Haley, N.Rebecca.; Ballen, K. 2002: In utero or ex utero cord blood collection: Which is better?. Transfusion 42(10): 1261-1267

Wiemels, J.L.; Xiao, Z.; Buffler, P.A.; Maia, A.T.; Ma, X.; Dicks, B.M.; Smith, M.T.; Zhang, L.; Feusner, J.; Wiencke, J.; Pritchard-Jones, K.; Kempski, H.; Greaves, M. 2002: In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 99(10): 3801-3805

Moore, R.J.; Strachan, B.K.; Tyler, D.J.; Duncan, K.R.; Baker, P.N.; Worthington, B.S.; Johnson, I.R.; Gowland, P.A. 2000: In utero perfusing fraction maps in normal and growth restricted pregnancy measured using IVIM echo-planar MRi. Placenta 21(7): 726-732

Devereux, G.; Seaton, A.; Barker, R.N. 2001: In utero priming of allergen-specific helper T cells. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 31(11): 1686-1695

Barker, D.J. 2000: In utero programming of cardiovascular disease. Theriogenology 53(2): 555-574

Hsiao, S.M.; Wu, M.H.; Shih, J.C.; Hsieh, F.J. 2001: In utero progressive pulmonary stenosis successfully treated with transcatheter intervention after delivery. Journal of the Formosan Medical Association 100(5): 347-349

Bolaris, S.; Bozas, E.; Benekou, A.; Philippidis, H.; Stylianopoulou, F. 2001: In utero radiation-induced apoptosis and p53 gene expression in the developing rat brain. International Journal of Radiation Biology 77(1): 71-81

Benekou, A.; Bolaris, S.; Kazanis, E.; Bozas, E.; Philippidis, H.; Stylianopoulou, F. 2001: In utero radiation-induced changes in growth factor levels in the developing rat brain. International Journal of Radiation Biology 77(1): 83-93

Clyman, R.I.; Chen, Y.Q.; Chemtob, S.; Mauray, F.; Kohl, T.; Varma, D.R.; Roman, C. 2001: In utero remodeling of the fetal lamb ductus arteriosus: the role of antenatal indomethacin and avascular zone thickness on vasa vasorum proliferation, neointima formation, and cell death. Circulation 103(13): 1806-1812

Bruner, J.P.; Tulipan, N.B.; Richards, W.O.; Walsh, W.F.; Boehm, F.H.; Vrabcak, E.K. 2000: In utero repair of myelomeningocele: a comparison of endoscopy and hysterotomy. Fetal Diagnosis and Therapy 15(2): 83-88

Chiba, T.; Albanese, C.T.; Jennings, R.W.; Filly, R.A.; Farrell, J.A.; Harrison, M.R. 2000: In utero repair of rectal atresia after complete resection of a sacrococcygeal teratoma. Fetal Diagnosis and Therapy 15(3): 187-190

Hossaini, A.; Dalgaard, M.; Vinggaard, A.M.; Frandsen, H.; Larsen, J.J. 2001: In utero reproductive study in rats exposed to nonylphenol. Reproductive Toxicology 15(5): 537-543

Flake, A.W. 1999: In utero stem cell transplantation for the treatment of genetic diseases. Schweizerische Medizinische Wochenschrift 129(46): 1733-1739

Sawaki, M.; Noda, S.; Muroi, T.; Mitoma, H.; Takakura, S.; Sakamoto, S.; Yamasaki, K. 2003: In utero through lactational exposure to ethinyl estradiol induces cleft phallus and delayed ovarian dysfunction in the offspring. Toxicological Sciences: An Official Journal of the Society of Toxicology 75(2): 402-411

Chapon, C.; Franconi, F.; Roux, J.; Marescaux, L.; Le Jeune, J.J.; Lemaire, L. 2002: In utero time-course assessment of mouse embryo development using high resolution magnetic resonance imaging. Anatomy and Embryology 206(1-2): 131-137

Tran, N.D.; Porada, C.D.; Zhao, Y.; Almeida-Porada, G.; Anderson, W.F.; Zanjani, E.D. 2000: In utero transfer and expression of exogenous genes in sheep. Experimental Hematology 28(1): 17-30

Casal, M.L.; Wolfe, J.H. 2001: In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of beta-glucuronidase can delay onset of clinical signs. Blood 97(6): 1625-1634

Turner, C.W.; Archer, D.R.; Wong, J.; Yeager, A.M.; Fleming, W.H. 1998: In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice. British Journal of Haematology 103(2): 326-334

Chan, A.Y.; Silverman, R.K.; Smith, F.C.; Geifman-Holtzman, O. 1999: In utero treatment of fetal complete heart block with terbutaline. A case report. Journal of Reproductive Medicine 44(4): 385-387

Turnbull, D.H. 1999: In utero ultrasound backscatter microscopy of early stage mouse embryos. Computerized Medical Imaging and Graphics: the Official Journal of the Computerized Medical Imaging Society 23(1): 25-31

Derrick, C.W.; Lord, L. 1998: In utero varicella-zoster infections. Southern Medical Journal 91(11): 1064-1066

Kattainen, H.; Tuukkanen, J.; Simanainen, U.; Tuomisto, J.T.; Kovero, O.; Lukinmaa, P.L.; Alaluusua, S.; Tuomisto, J.; Viluksela, M. 2001: In utero/lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure impairs molar tooth development in rats. Toxicology and Applied Pharmacology 174(3): 216-224

Cherrington, J.M.; Fuller, M.D.; Lamy, P.D.; Miner, R.; Lalezari, J.P.; Nuessle, S.; Drew, W.L. 1998: In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome. Journal of Infectious Diseases 178(6): 1821-1825

Resnick, S.M.; Zehnder, A.J. 2000: In vitro ATP regeneration from polyphosphate and AMP by polyphosphate:AMP phosphotransferase and adenylate kinase from Acinetobacter johnsonii 210A. Applied and Environmental Microbiology 66(5): 2045-2051

Li, D.; Firozi, P.F.; Chang, P.; Wang, L.E.; Xiong, P.; Sturgis, E.M.; Eicher, S.A.; Spitz, M.R.; Hong, W.K.; Wei, Q. 2001: In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. International Journal of Cancer 93(3): 436-440

Liberto, M.Carla.; Matera, G.; Lamberti, A.G.; Barreca, G.S.; Quirino, A.; Focà, A. 2003: In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells. Diagnostic Microbiology and Infectious Disease 45(2): 107-115

Choteau, M.; Lataillade, J.J.; Sanchez, A.; Dupuy, C.; Bourin, P. 1998: In vitro CD34+ cell expansion: A 7 medium comparison. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1998(19): 23-24

Stobbe, I.; van der Meer-Prins, E.M.; de Lange, P.; Oudshoorn, M.; Doxiadis, I.I.; Claas, F.H. 2000: In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching. Human Immunology 61(9): 879-883

Ito, M.; Yokouchi, K.; Naito, K.; Endo, H.; Hakamata, Y.; Miyazaki, J-Ichi.; Tojo, H. 2002: In vitro Cre/loxP system in cells from developing gonads: Investigation of the Sry promoter. Development Growth and Differentiation 44(6): 549-557

Park, M.; Loeppky, R.N. 2000: In vitro DNA deamination by alpha-nitrosaminoaldehydes determined by GC/MS-SIM quantitation. Chemical Research in Toxicology 13(2): 72-81

Abe, T.; Takano, H.; Sasaki, N.; Mori, K.; Kawano, S. 2000: In vitro DNA fragmentation of mitochondrial DNA caused by single-stranded breakage related to macroplasmodial senescence of the true slime mold, Physarum polycephalum. Current Genetics 37(2): 125-135

Duarte, V.; Gasparutto, D.; Jaquinod, M.; Cadet, J. 2000: In vitro DNA synthesis opposite oxazolone and repair of this DNA damage using modified oligonucleotides. Nucleic Acids Research 28(7): 1555-1563

Ackermann, J.; Wlotzka, B.; Mccaskill, J.S. 1998: In vitro DNA-based predator-prey system with oscillatory kinetics. Bulletin of Mathematical Biology 60(2): 329-354

Mckenna, S.; Beloin, C.; Dorman, C.J. 2003: In vitro DNA-binding properties of VirB, the Shigella flexneri virulence regulatory protein. FEBS Letters 545(2-3): 183-187

Dumont Beboux, N.; Anholt, B.; Von Aderkas, P. 1999: In vitro Douglas fir pollen germination: Influence of hydration, sucrose and polyethylene glycol. Annals of Forest Science 56(1): 11-18

Bosveld, A.T.C.; de Bie, P.A.F.; van den Brink, N.W.; Jongepier, H.; Klomp, A.V. 2002: In vitro EROD induction equivalency factors for the 10 PAHs generally monitored in risk assessment studies in The Netherlands. Chemosphere 49(1): 75-83

Matsunaga, E.; Uno, M.; Endo, S.; Kuroda, K.; Nagatsuka, Y.; Usui, Y.; Shimizu, K.; Kida, A. 2001: In vitro Epstein-Barr virus infection to the epithelial cell lines derived from head and neck squamous cell cancer (HNSCC). Nichidai Igaku Zasshi 60(9): 419-425

Jones, R.N.; Hare, R.S.; Sabatelli, F.J. 2001: In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial. Journal of Antimicrobial ChemoTherapy 47(1): 15-25

Young, J.M.; Ffrench, R.A.; Clarkson, J.D.; Stewart, G.J.; Liang, T.; Tideman, R.L.; Packham, D.; Fulcher, D.A.; Benson, E.M. 2001: In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12). Aids Research and Human Retroviruses 17(3): 233-242

Nakamura, T.; Kloetzer, W.S.; Brams, P.; Hariharan, K.; Chamat, S.; Cao, X.; LaBarre, M.J.; Chinn, P.C.; Morena, R.A.; Shestowsky, W.S.; Li, Y.P.; Chen, A.; Reff, M.E. 2000: In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. International Journal of Immunopharmacology 22(2): 131-141

Sopo, S.-Miceli; Federico, G.; Parenti, D.; Alecci, M.-Concetta; Zorzi, G.; Stabile, A. 2001: In vitro IgE synthesis in neonates with or without a family history of atopy. Pediatric Asthma Allergy and Immunology 15(2): 97-105

Linez-Bataillon, P.; Monchau, F.; Bigerelle, M.; Hildebrand, H.F. 2002: In vitro MC3T3 osteoblast adhesion with respect to surface roughness of Ti6Al4V substrates. Biomolecular Engineering 19(2-6): 133-141

Tosi, M.R.; Tugnoli, V.; Bottura, G.; Lucchi, P.; Battaglia, A.; Giorgianni, P.; Ferri, C.; Mannini, D.; Reggiani, A. 2000: In vitro MRS and HPLC studies on human renal cell carcinomas. Oncology Reports 7(6): 1355-1358

Bender, M.; Orchardo, J.; Dickson, M.L.; Barber, R.; Lindley, S. 1999: In vitro O2 fluxes compared with 14C production and other rate terms during the JGOFS Equatorial Pacific experiment. Deep-Sea Research Part I Oceanographic Research Papers 46(4): 637-654

Boulton, D.W.; DeVane, C.Lindsay.; Liston, H.L.; Markowitz, J.S. 2002: In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sciences 71(2): 163-169

Xing, T.; Wu, F.; Brodin, O.; Fasth, K.J.; Långström, B.; Bergström, M. 2000: In vitro PET evaluations in lung cancer cell lines. Anticancer Research 20(3a): 1375-1380

Laliberté, F.; Liu, S.; Gorseth, E.; Bobechko, B.; Bartlett, A.; Lario, P.; Gresser, M.J.; Huang, Z. 2002: In vitro PKA phosphorylation-mediated human PDE4A4 activation. FEBS Letters 512(1-3): 205-208

Ziegler, H.L.; Staerk, D.; Christensen, J.; Hviid, L.; Hägerstrand, H.; Jaroszewski, J.W. 2002: In vitro Plasmodium falciparum drug sensitivity assay: inhibition of parasite growth by incorporation of stomatocytogenic amphiphiles into the erythrocyte membrane. Antimicrobial Agents and ChemoTherapy 46(5): 1441-1446

Lai, V.C.H.; Dempsey, S.; Lau, J.Y.N.; Hong, Z.; Zhong, W. 2003: In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus. Journal of Virology 77(3): 2295-2300

You, S.; Falgout, B.; Markoff, L.; Padmanabhan, R. 2001: In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5'- and 3'-terminal regions that influence RNA structure. Journal of Biological Chemistry 276(19): 15581-15591

Smith, C.R.; Jaramillo, Aés.; Poindexter, N.J.; Steward, N.S.; Lu, K.C.; Brennan, D.C.; Singer, G.G.; Miller, B.W.; Jendrisak, M.D.; Shenoy, S.; Lowell, J.A.; Howard, T.K.; Mohanakumar, T. 2002: In vitro T cell proliferation from kidney allograft biopsies with unremarkable pathology: new strategies for an old problem. Transplantation 73(1): 142-145

van der Geld, Y.M.; Huitema, M.G.; Franssen, C.F.; van der Zee, R.; Limburg, P.C.; Kallenberg, C.G. 2000: In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG). Clinical and Experimental Immunology 122(3): 504-513

Epperson, D.E.; Margolis, D.A.; McOlash, L.; Janczak, T.; Barrett, A.J. 2001: In vitro T-cell receptor V beta repertoire analysis may identify which T-cell V beta families mediate graft-versus-leukaemia and graft-versus-host responses after human leucocyte antigen-matched sibling stem cell transplantation. British Journal of Haematology 114(1): 57-62

Luque, I.; Leyva, L.; José Torres, M.; Rosal, M.; Mayorga, C.; Segura, J.M.; Blanca, M.; Juárez, C. 2001: In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 56(7): 611-618

Liu, M.Y.; Hsieh, W.C.; Yang, B.C. 2000: In vitro aberrant gene expression as the indicator of lead-induced neurotoxicity in U-373MG cells. Toxicology 147(1): 59-64

Murakami, A.; Wada, K.; Ueda, N.; Sasaki, K.; Haga, M.; Kuki, W.; Takahashi, Y.; Yonei, H.; Koshimizu, K.; Ohigashi, H. 2000: In vitro absorption and metabolism of a citrus chemopreventive agent, auraptene, and its modifying effects on xenobiotic enzyme activities in mouse livers. Nutrition and Cancer 36(2): 191-199

Kraeling, M.E.K.; Bronaugh, R.L. 2003: In vitro absorption of triethanolamine through human skin. Journal of Toxicology Cutaneous and Ocular Toxicology 22(3): 137-145

Hetrakul, N.; Civelek, A.C.; Stagg, C.A.; Udelsman, R. 2001: In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 130(6): 1011-1018

Nagashima, Y.; Toyoda, M.; Hasobe, M.; Shimakura, K.; Shiomi, K. 2003: In vitro accumulation of tetrodotoxin in pufferfish liver tissue slices. Toxicon: Official Journal of the International Society on Toxinology 41(5): 569-574

Tsai, C.-L.; Lin, Y.-T.; Huang, S.-T.; Chang, H.-W. 2002: In vitro acid resistance of CO2 and Nd-YAG laser-treated human tooth enamel. Caries Research 36(6): 423-429

Nwaga, D.; Nkot, L.N.o 1998: In vitro acidity tolerance of rhizobia isolated from Vigna unguiculata in Cameroon in comparison to Bradyrhizobium japonicum. Cahiers Agricultures 7(5): 407-410

Moran, C.M.; Watson, R.J.; Fox, K.A.A.; Mcdicken, W.N. 2002: In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz. Ultrasound in Medicine and Biology 28(6): 785-791

Cardoso, L.; Teboul, F.éd.ér.; Sedel, L.; Oddou, C.; Meunier, A. 2003: In vitro acoustic waves propagation in human and bovine cancellous bone. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 18(10): 1803-1812

Müller, G.; Kramer, A. 2000: In vitro action of a combination of selected antimicrobial agents and chondroitin sulfate. Chemico-Biological Interactions 124(2): 77-85

Tsao, N.; Luh, T-Yau.; Chou, C-Kung.; Chang, T-Yu.; Wu, J-Jong.; Liu, C-Chuan.; Lei, H-Yao. 2002: In vitro action of carboxyfullerene. Journal of Antimicrobial ChemoTherapy 49(4): 641-649

Rahmy, T.R.; Ayoub, M.A. 2002: In vitro action of cobra venom on goat spermatozoa ultrastructure by transmission and scanning electron microscopy. Journal of Venomous Animals and Toxins 8(1)

Bregenholt, S.; Brimnes, J.; Nissen, M.H.; Claesson, M.H. 1999: In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts. Clinical and Experimental Immunology 118(2): 228-234

Bowman, W.C.; Du, S.; Bauer, C.E.; Kranz, R.G. 1999: In vitro activation and repression of photosynthesis gene transcription in Rhodobacter capsulatus. Molecular Microbiology 33(2): 429-437

Niwa, T.; Shiraga, T.; Yamasaki, S.; Ishibashi, K.; Ohno, Y.; Kagayama, A. 2003: In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 33(7): 717-729

Mohamadin, A.M.; Abdel-Naim, A.B. 2003: In vitro activation of dibromoacetonitrile to cyanide: role of xanthine oxidase. Archives of Toxicology 77(2): 86-93

Hess, A.; Labbé, D.; Michel, O.; Teranishi, M-aki.; Orzechowska, O.; Schmidt, A.; Addicks, K.; Bloch, W. 2002: In vitro activation of extracellular signal-regulated kinase1/2 in the inner ear of guinea pigs. Brain Research 956(2): 236-245

Ahmed, F.; Vyas, V.; Cornfield, A.; Goodin, S.; Ravikumar, T.S.; Rubin, E.H.; Gupta, E. 1999: In vitro activation of irinotecan to SN-38 by human liver and intestine. Anticancer Research 19(3a): 2067-2071

Escribano, J.; Díaz-Guerra, M.J.; Riese, H.H.; Ontañón, J.; García-Olmo, D.; García-Olmo, D.C.; Rubio, A.; Fernández, J.A. 1999: In vitro activation of macrophages by a novel proteoglycan isolated from corms of Crocus sativus L. Cancer Letters 144(1): 107-114

Biswas, S.K.; Sodhi, A. 2002: In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 22(5): 527-538

Hahm, M.S.; Bae, J.H.; Choi, E.S.; Chung, B.H. 1999: In vitro activation of yeast pro-carboxypeptidase Y expressed as inclusion bodies in Escherichia coli. Biotechnology Letters 21(10): 881-885

Zhang Huilin; Feng Ping; Lu Xiaoju; Yu Rujia; Zhou Zhiqiang; Zhu Shumin; Cheng Weizhao; Tao Chuanmin; Xu Jin 1998: In vitro activities of 11 antibacterial agents including vancomycin against Staphylococci. Zhongguo Kangshengsu Zazhi 23(6): 419;449-452

Muñoz Bellido, J.L.; Alonso Manzanares, M.A.; Yagüe Guirao, G.; Gutiérrez Zufiaurre, M.N.; Toldos, M.C.; Segovia Hernández, M.; Garcia-Rodríguez, J.A. 1999: In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates. Antimicrobial Agents and ChemoTherapy 43(4): 966-968

Ryu, J.S.; Min, D.Y.; Kim, M.C.; Kim, N.S.; Shin, M.H. 2001: In vitro activities of 2,2'-dipyridyl against Trichomonas vaginalis, Candida albicans, and Gardnerella vaginalis. Journal of Microbiology and Biotechnology 11(1): 124-130

Pfaller, M.A.; Messer, S.A.; Boyken, L.; Huynh, H.; Hollis, R.J.; Diekema, D.J. 2002: In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrobial Agents and ChemoTherapy 46(11): 3518-3521

Goldstein, E.J.C.; Citron, D.M.; Merriam, C.Vreni.; Warren, Y.A.; Tyrrell, K.L.; Fernandez, H.T. 2003: In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. Antimicrobial Agents and ChemoTherapy 47(9): 3008-3011

Polidorou, F.; Moldobanidou, K.; Tsoukis, E.; Gioula, G.; Malaka, E. 2000: In vitro activities of Ampicillin/Sulbactam and Amoxicillin/Clavulanate against Acinetobacter baumannii. Deltion Ellenikes Mikrobiologikes Etaireias 45(3): 309-313

Zbinden, R.; Pünter, V.; von Graevenitz, A. 2002: In vitro activities of BAL9141, a novel broad-spectrum pyrrolidinone cephalosporin, against gram-negative nonfermenters. Antimicrobial Agents and ChemoTherapy 46(3): 871-874

Malay, S.; Roblin, P.M.; Reznik, T.; Kutlin, A.; Hammerschlag, M.R. 2002: In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Antimicrobial Agents and ChemoTherapy 46(2): 517-518

Zeckel, M.L.; Preston, D.A.; Allen, B.S. 2000: In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study. Antimicrobial Agents and ChemoTherapy 44(5): 1370-1374

Wexler, H.M.; Molitoris, D.; Finegold, S.M. 2000: In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 44(8): 2222-2224

Fuchs, P.C.; Barry, A.L.; Brown, S.D. 1999: In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agents. Antimicrobial Agents and ChemoTherapy 43(12): 2996-2997

Singh, K.V.; Malathum, K.; Murray, B.E. 2001: In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. Antimicrobial Agents and ChemoTherapy 45(12): 3640-3643

Pendland, S.L.; Prause, J.L.; Neuhauser, M.M.; Boyea, N.; Hackleman, J.M.; Danziger, L.H. 2000: In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori. Antimicrobial Agents and ChemoTherapy 44(9): 2518-2520

Bemer, P.; Juvin, M-Emmanuelle.; Bryskier, A.; Drugeon, H. 2003: In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates. Antimicrobial Agents and ChemoTherapy 47(9): 3025-3029

Weiss, W.J.; Petersen, P.J.; Jacobus, N.V.; Lin, Y.I.; Bitha, P.; Testa, R.T. 1999: In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems. Antimicrobial Agents and ChemoTherapy 43(3): 454-459

Bello, H.; Domínguez, M.; González, G.; Zemelman, R.; Mella, S.; Young, H.K.; Amyes, S.G. 2000: In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998. Journal of Antimicrobial ChemoTherapy 45(5): 712-713

Akova, M.; Gür, D.; Livermore, D.M.; Kocagöz, T.; Akalin, H.E. 1999: In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrobial Agents and ChemoTherapy 43(5): 1298-1300

Liaw, S-Jen.; Teng, L-Jene.; Hsueh, P-Ren.; Ho, S-Wu.; Luh, K-Tay. 2002: In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia. Journal of the Formosan Medical Association 101(7): 495-501

Kutlin, A.; Roblin, P.M.; Hammerschlag, M.R. 1999: In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrobial Agents and ChemoTherapy 43(9): 2268-2272

Williams, S.L.; Hartline, C.B.; Kushner, N.L.; Harden, E.A.; Bidanset, D.J.; Drach, J.C.; Townsend, L.B.; Underwood, M.R.; Biron, K.K.; Kern, E.R. 2003: In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses. Antimicrobial Agents and Chemotherapy 47(7): 2186-2192

Kashitani, F.; Fukuzawa, S.; Mori, C.; Murakami, H.; Yasui, K.; Yumoto, S.; Ishikawa, M.; Iwata, M.; Tateda, K.; Miyazaki, S.; Yamaguchi, K. 2000: In vitro activities of carbapenem antibiotics against the various clinical isolates. Japanese Journal of Antibiotics 53(1): 1-25

Steele-Moore, L.; Stark, K.; Holloway, W.J. 1999: In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. Antimicrobial Agents and ChemoTherapy 43(6): 1530

Barry, A.L.; Fuchs, P.C.; Brown, S.D. 2001: In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrobial Agents and ChemoTherapy 45(6): 1919-1922

Akins, R.L.; Rybak, M.J. 2000: In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model. Antimicrobial Agents and ChemoTherapy 44(7): 1925-1929

Schwab, U.; Gilligan, P.; Jaynes, J.; Henke, D. 1999: In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens. Antimicrobial Agents and ChemoTherapy 43(6): 1435-1440

Livermore, D.M.; Carter, M.W.; Bagel, S.; Wiedemann, B.; Baquero, F.; Loza, E.; Endtz, H.P.; van Den Braak, N.; Fernandes, C.J.; Fernandes, L.; Frimodt-Moller, N.; Rasmussen, L.S.; Giamarellou, H.; Giamarellos-Bourboulis, E.; Jarlier, V.; Nguyen, J.; Nord, C.E.; Struelens, M.J.; Nonhoff, C.; Turnidge, J.; Bell, J.; Zbinden, R.; Pfister, S.; Mixson, L.; Shungu, D.L. 2001: In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrobial Agents and ChemoTherapy 45(6): 1860-1867

Fuchs, P.C.; Barry, A.L.; Brown, S.D. 2001: In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrobial Agents and ChemoTherapy 45(6): 1915-1918

Wexler, H.M.; Molitoris, D.; St John, S.; Vu, A.; Read, E.K.; Finegold, S.M. 2002: In vitro activities of faropenem against 579 strains of anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 46(11): 3669-3675

De Azavedo, J.C.; Trpeski, L.; Pong-Porter, S.; Matsumura, S.; Low, D.E. 1999: In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada. Antimicrobial Agents and ChemoTherapy 43(9): 2299-2301

Schaumann, R.; Ackermann, G.; Pless, B.; Claros, M.C.; Goldstein, E.J.; Rodloff, A.C. 2000: In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. International Journal of Antimicrobial Agents 16(3): 225-232

Goldstein, E.J.C.; Citron, D.M.; Merriam, C.Vreni.; Warren, Y.A.; Tyrrell, K.L.; Fernandez, H.T. 2002: In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Antimicrobial Agents and ChemoTherapy 46(12): 3995-3996

Schaumann, R.; Ackermann, G.; Pless, B.; Claros, M.C.; Rodloff, A.C. 1999: In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria. Antimicrobial Agents and ChemoTherapy 43(11): 2783-2786

Roblin, P.M.; Reznik, T.; Kutlin, A.; Hammerschlag, M.R. 1999: In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae. Antimicrobial Agents and ChemoTherapy 43(11): 2806-2807

García, M.T.; Pelaz, C.; Giménez, M.J.; Aguilar, L. 2000: In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results. Antimicrobial Agents and ChemoTherapy 44(8): 2176-2178

Paphitou, N.I.; Ostrosky-Zeichner, L.; Paetznick, V.L.; Rodriguez, J.R.; Chen, E.; Rex, J.H. 2002: In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrobial Agents and ChemoTherapy 46(10): 3298-3300

Martínez-Martínez, L.; Pascual, A.; Suárez, A.I.; Perea, E.J. 1998: In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria. Antimicrobial Agents and ChemoTherapy 42(12): 3290-3292

Zarazaga, M.; Sáenz, Y.; Portillo, A.; Tenorio, C.; Ruiz-Larrea, F.; Del Campo, R.; Baquero, F.; Torres, C. 1999: In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. Antimicrobial Agents and ChemoTherapy 43(12): 3039-3041

Saez Nieto, J.A.; Vazquez, J.A. 1999: In vitro activities of ketolides HRM 3647 and HRM 3004, levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis. Antimicrobial Agents and Chemotherapy 43(4): 983-984

Zou-Jun; Li-Xin-Xin; Yang-Zhao-Xu; Zhang-Lei 2003: In vitro activities of levofloxacin against Helicobacter pylori. Zhongguo Kangshengsu Zazhi 28(5): 292-294

Noskin, G.A.; Siddiqui, F.; Stosor, V.; Hacek, D.; Peterson, L.R. 1999: In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrobial Agents and ChemoTherapy 43(8): 2059-2062

Hirschl, A.M.; Apfalter, P.; Makristathis, A.; Rotter, M.L.; Wimmer, M. 2000: In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. Antimicrobial Agents and ChemoTherapy 44(7): 1977-1979

Giacometti, A.; Cirioni, O.; Greganti, G.; Quarta, M.; Scalise, G. 1998: In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria. Antimicrobial Agents and ChemoTherapy 42(12): 3320-3324

Giacometti, A.; Cirioni, O.; Del Prete, M.S.; Barchiesi, F.; Fortuna, M.; Drenaggi, D.; Scalise, G. 2000: In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia. Antimicrobial Agents and ChemoTherapy 44(6): 1716-1719

Abadi, F.J.; Yakubu, D.E.; Pennington, T.H. 1999: In vitro activities of meropenem and other antimicrobial agents against British meningococcal isolates. ChemoTherapy 45(4): 253-257

Rybak, R.J.; Hartline, C.B.; Qiu, Y.L.; Zemlicka, J.; Harden, E.; Marshall, G.; Sommadossi, J.P.; Kern, E.R. 2000: In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections. Antimicrobial Agents and ChemoTherapy 44(6): 1506-1511

Peh, H.L.; Toh, A.; Murugasu-Oei, B.; Dick, T. 2001: In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli. Antimicrobial Agents and ChemoTherapy 45(8): 2403-2404

Hamamoto, K.; Shimizu, T.; Fujimoto, N.; Zhang, Y.; Arai, S. 2001: In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae. Antimicrobial Agents and ChemoTherapy 45(6): 1908-1910

Kim, S.; Kim, S.S.; Bang, Y.Jue.; Kim, S.Jin.; Lee, B.Jae. 2003: In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides 24(7): 945-953

Ubukata, K.; Iwata, S.; Sunakawa, K. 2003: In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 9(3): 221-226

Appleman, M.D.; Belzberg, H.; Citron, D.M.; Heseltine, P.N.; Yellin, A.E.; Murray, J.; Berne, T.V. 2000: In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrobial Agents and ChemoTherapy 44(4): 1035-1040

Jamieson, C.E.; Lambert, P.A.; Simpson, I.N. 2003: In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms. Antimicrobial Agents and ChemoTherapy 47(8): 2615-2618

Nagano, R.; Shibata, K.; Adachi, Y.; Imamura, H.; Hashizume, T.; Morishima, H. 2000: In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrobial Agents and ChemoTherapy 44(3): 489-495

Rebuck, J.A.; Olsen, K.M.; Fey, P.D.; Bergman, K.L.; Rupp, M.E. 2000: In vitro activities of parenteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic Escherichia coli host. Journal of Antimicrobial ChemoTherapy 46(3): 461-464

Mikamo, H.; Sato, Y.; Hayasaki, Y.; Kawazoe, K.; Tamaya, T. 1999: In vitro activities of pazufloxacin, a novel injectable quinolone, against bacteria causing infections in obstetric and gynecological patients. ChemoTherapy 45(3): 154-157

Giacometti, A.; Cirioni, O.; Ancarani, F.; Del Prete, M.S.; Fortuna, M.; Scalise, G. 1999: In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. Antimicrobial Agents and ChemoTherapy 43(8): 2093-2096

Allen, G.P.; Cha, R.; Rybak, M.J. 2002: In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrobial Agents and ChemoTherapy 46(8): 2606-2612

Hwang, S.H.; Kim, M.N.; Pai, C.H.; Huh, D.H.; Shin, W.S. 2000: In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea. Yonsei Medical Journal 41(5): 563-569

Kawakami, Y.; Akahane, T.; Yamaguchi, M.; Oana, K.; Takahashi, Y.; Okimura, Y.; Okabe, T.; Gotoh, A.; Katsuyama, T. 2000: In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori. Antimicrobial Agents and ChemoTherapy 44(2): 458-461

Pfaller, M.A.; Messer, S.A.; Hollis, R.J.; Jones, R.N.; Diekema, D.J. 2002: In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrobial Agents and ChemoTherapy 46(6): 1723-1727

Roblin, P.M.; Reznik, T.; Kutlin, A.; Hammerschlag, M.R. 2003: In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Antimicrobial Agents and ChemoTherapy 47(3): 1135-1136

Shoen, C.M.; Choromanska, O.; Reynolds, R.C.; Piper, J.R.; Johnson, C.A.; Cynamon, M.H. 1998: In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex. Antimicrobial Agents and ChemoTherapy 42(12): 3315-3316

Milatovic, D.; Schmitz, F.J.; Brisse, S.; Verhoef, J.; Fluit, A.C. 2000: In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy 44(4): 1102-1107

Ruiz-Serrano, M.J.; Alcalá, L.; Martínez, L.; Díaz, M.; Marín, M.; González-Abad, M.J.; Bouza, E. 2000: In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs. Antimicrobial Agents and ChemoTherapy 44(9): 2567-2568

Linde, H.J.; Schmidt, M.; Fuchs, E.; Reischl, U.; Niller, H.H.; Lehn, N. 2001: In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrobial Agents and ChemoTherapy 45(5): 1553-1557

Song Zhen Min 2002: In vitro activities of teicoplanin against Staphylococci. Zhongguo Xinyao yu Linchuang Zazhi 21(8): 477-479

Liu, Y.n Chun; Uchiyama, Kohji; Natsui, Naomi; Hasegawa, Yasushi 2002: In vitro activities of the components from scallop shells. Fisheries Science 68(6): 1330-1336

Boucher, H.W.; Wennersten, C.B.; Eliopoulos, G.M. 2000: In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrobial Agents and ChemoTherapy 44(8): 2225-2229

Schmitz, F.-J.; Schwarz, S.; Milatovic, D.; Verhoef, J.; Fluit, A.C. 2002: In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. Journal of Antimicrobial ChemoTherapy 50(1): 145-148

Rastogi, N.; Goh, K.S.; Berchel, M.; Bryskier, A. 2000: In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4. Antimicrobial Agents and ChemoTherapy 44(10): 2848-2852

Jalava, J.; Kataja, J.; Seppälä, H.; Huovinen, P. 2001: In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrobial Agents and ChemoTherapy 45(3): 789-793

Kearney, J.A.; Barbadora, K.; Mason, E.O.; Wald, E.R.; Green, M. 1999: In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. International Journal of Antimicrobial Agents 12(2): 141-144

Barry, A.L.; Fuchs, P.C.; Brown, S.D. 2001: In vitro activities of three nonfluorinated quinolones against representative bacterial isolates. Antimicrobial Agents and ChemoTherapy 45(6): 1923-1927

Betriu, C.; Rodríguez-Avial, I.; Sánchez, B.Ali.; Gómez, Mía.; Alvarez, J.; Picazo, J.J. 2002: In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrobial Agents and Chemotherapy 46(3): 892-895

Malathum, K.; Coque, T.M.; Singh, K.V.; Murray, B.E. 1999: In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrobial Agents and ChemoTherapy 43(4): 930-936

Jiang, Z.D.; Ke, S.; Palazzini, E.; Riopel, L.; Dupont, H. 2000: In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrobial Agents and ChemoTherapy 44(8): 2205-2206

Kays, M.B.; Denys, G.A. 2001: In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics. Clinical Therapeutics 23(3): 413-424

Kays, M.B.; Wood, K.K.; Miles, D.O. 1999: In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri. PharmacoTherapy 19(11): 1308-1314

Ling, T.K.; Fung, K.S.; Cheng, A.F. 2001: In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid). ChemoTherapy 47(4): 243-249

Shen, Z.; Sun, Z.; Wang, H. 1998: In vitro activity comparison of 16 antibacterial agents against Gram-negative isolates from immunocompromised patients. Zhongguo Kangshengsu Zazhi 23(5): 346-350

Rhomberg, P.R.; Jones, R.N. 2002: In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum. Diagnostic Microbiology and Infectious Disease 42(2): 145-147

Jamal, W.Y.; Mokaddas, E.M.; Verghese, T.L.; Rotimi, V.O. 2002: In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait. International Journal of Antimicrobial Agents 20(4): 270-274

Duh, R.W.; Singh, K.V.; Malathum, K.; Murray, B.E. 2001: In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Microbial Drug Resistance 7(1): 39-46

Wootton, M.; Howe, R.A.; Walsh, T.R.; Bennett, P.M.; MacGowan, A.P. 2002: In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA). Journal of Antimicrobial ChemoTherapy 50(5): 760-761

Ellabib, M.S.; ElJariny, I.A. 2001: In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens. Saudi Medical Journal 22(10): 860-863

Fluhr, J.W.; Gloor, M.; Dietz, P.; Höffler, U. 1999: In vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 289(1): 53-61

Strigl, S.; Roblin, P.M.; Reznik, T.; Hammerschlag, M.R. 2000: In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrobial Agents and ChemoTherapy 44(4): 1112-1113

Edelstein, P.H.; Higa, F.; Edelstein, M.A. 2001: In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and ChemoTherapy 45(10): 2685-2690

Sillerström, E.; Wahlund, E.; Nord, C.E. 2000: In vitro activity of ABT-773 against anaerobic bacteria. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 19(8): 635-637

Dubois, J.; St -Pierre, C. 2001: In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens. Diagnostic Microbiology and Infectious Disease 40(1-2): 35-40

Brueggemann, A.B.; Doern, G.V.; Huynh, H.K.; Wingert, E.M.; Rhomberg, P.R. 2000: In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrobial Agents and ChemoTherapy 44(2): 447-449

Fluit, A.C.; Schmitz, F.-J.; Verhoef, J.; Milatovic, D. 2002: In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci. Journal of Antimicrobial ChemoTherapy 50(2): 271-276

Gomes, A.P.; Ramos, M.L.; Vasconcellos, R.S.; Jensen, J.R.; Vieira-Bressan, M.C.; Araujo, J.V. 2000: In vitro activity of Brazilian strains of the predatory fungi Arthrobotrys spp. on free-living nematodes and infective larvae of Haemonchus placei. Memorias do Instituto Oswaldo Cruz 95(6): 873-876

Okuda, J.; Otsuki, M.; Oh, T.; Nishino, T. 2000: In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins. Journal of Antimicrobial ChemoTherapy 46(1): 101-108

Nakai, T.; Uno, J.; Otomo, K.; Ikeda, F.; Tawara, S.; Goto, T.; Nishimura, K.; Miyaji, M. 2002: In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds. ChemoTherapy 48(2): 78-81

Patel, R.; Rouse, M.S.; Piper, K.E.; Steckelberg, J.M. 2000: In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 38(3): 177-179

Fuchs, P.C.; Barry, A.L.; Brown, S.D. 2000: In vitro activity of Gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria. Diagnostic Microbiology and Infectious Disease 38(4): 243-253

Wexler, H., M.; Molitoris, E.; Molitoris, D.; Finegold, S., M. 1999: In vitro activity of HMR 3004 (RU 64004) against 502 strains of anaerobic bacteria. Anaerobe 5(2): 65-68

Watanabe, A.; Tokue, Y.; Takahashi, H.; Kikuchi, T.; Kobayashi, T.; Gomi, K.; Fujimura, S.; Nukiwa, T. 1999: In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections. Antimicrobial Agents and ChemoTherapy 43(7): 1767-1768

Sillerström, E.; Wahlund, E.; Nord, C.E. 1999: In vitro activity of LY 333328 against anaerobic gram-positive bacteria. Journal of ChemoTherapy 11(2): 90-92

Al-Nawas, B.; Swantes, J.; Shah, P.M. 2000: In vitro activity of LY333328, a new glycopeptide, against extracellular and intracellular vancomycin-resistant enterococci. Infection 28(4): 214-218

Pullar, I.A.; Boot, J.R.; Carney, S.L.; Cohen, M.L.; Colvin, E.M.; Conway, R.G.; Hardy, C.H.; Lucaites, V.L.; Nelson, D.L.; Schenck, K.W.; Tomlinson, R.; Wedley, S. 2001: In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties. European Journal of Pharmacology 432(1): 9-17

Widmann, C.; Sather, S.; Oyer, R.; Johnson, G.L.; Dreskin, S.C. 2001: In vitro activity of MEKK2 and MEKK3 in detergents is a function of a valine to serine difference in the catalytic domain. Biochimica et Biophysica Acta 1547(1): 167-173

Kato, N.; Tanaka, K.; Kato, H.; Watanabe, K. 2000: In vitro activity of R-95867, the active metabolite of a new oral carbapenem, CS-834, against anaerobic bacteria. Journal of Antimicrobial ChemoTherapy 45(3): 357-361

Messick, C.R.; Woodward, J.; Pendland, S.L. 1998: In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci. Diagnostic Microbiology and Infectious Disease 32(2): 95-99

Fujimura, T.; Yamano, Y.; Yoshida, I.; Shimada, J.; Kuwahara, S. 2003: In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Antimicrobial Agents and ChemoTherapy 47(3): 923-931

Edelstein, P.H.; Edelstein, M.A. 1999: In vitro activity of SCH 27899 (Ziracin) against Legionella species. Diagnostic Microbiology and Infectious Disease 33(1): 59-62

Neurath, A.R.; Li, Y.Y.; Mandeville, R.; Richard, L. 2000: In vitro activity of a cellulose acetate phthalate topical cream against organisms associated with bacterial vaginosis. Journal of Antimicrobial ChemoTherapy 45(5): 713-714

Swenson, J.M.; Tenover, F.C. 2002: In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus. Journal of Antimicrobial ChemoTherapy 49(5): 845-850

Parrish, N.M.; Houston, T.; Jones, P.B.; Townsend, C.; Dick, J.D. 2001: In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis. Antimicrobial Agents and ChemoTherapy 45(4): 1143-1150

Valera, L.; Gradelski, E.; Huczko, E.; Washo, T.; Yigit, H.; Fung-Tomc, J. 2002: In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates. Journal of Antimicrobial ChemoTherapy 50(1): 140-142

Weiss, K.; de Azavedo, J.; Restieri, C.; Quach, C.; Laverdiere, M.; Rubin, E.; Gourdeau, M.; Low, D.E. 2001: In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae. Journal of Antimicrobial ChemoTherapy 48(3): 407-409

Primache, V.; Binda, S.; De Benedittis, G.; Barbi, M. 1998: In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus. New Microbiologica 21(4): 397-401

Tanaka, K.; Kato, N.; Watanabe, K. 2000: In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes. Journal of Antimicrobial ChemoTherapy 46(3): 465-469

Soares, M.M.gali Stelato Rocha; Cury, A.E.ily 2001: In vitro activity of antifungal and antiseptic agents against dermatophyte isolates from patients with tinea pedis. Brazilian Journal of Microbiology 32(2): 130-134

Sánchez, L.; Londoño, D.; Arango, A.I.; Mattar, S. 1999: In vitro activity of antituberculous agents against Mycobacterium tuberculosis isolates from Bogota, DC (Colombia) evaluated by the ETest. Diagnostic Microbiology and Infectious Disease 35(2): 109-112

Fernández-Cuenca, F.; Martínez-Martínez, L.; Pascual, A.; Perea, E.J. 2003: In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii. Chemotherapy 49(1-2): 24-26

Carricajo, A.; Fonsale, N.; Vautrin, A.C.; Aubert, G. 2000: In vitro activity of beta-lactams against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus. Journal of Antimicrobial ChemoTherapy 46(5): 856-858

Song, W.; Woo, H.J.; Kim, J.S.; Lee, K.M. 2003: In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 21(1): 8-12

Nagy, E.; Marton, A.; Hajdú, E. 2003: In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary. Acta Microbiologica et Immunologica Hungarica 50(2-3): 119-124

Reinert, R.R.; Al-Lahham, A.; Lütticken, R. 2001: In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. Journal of antimicrobial chemotherapy 48(2): 279-281

Gomez-Lus, R.; Navarro, C.; Egido, P.; Aspiroz, C.; Goñi, P.; Vergara, Y.; Garcia, C.; Duran, E.; Castillo, J.; Rubio, M.C. 2000: In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Journal of ChemoTherapy 12(1): 17-21

Bonfiglio, G.; Marchetti, F. 2000: In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams. ChemoTherapy 46(4): 229-234

Deshpande, L.; Pfaller, M.A.; Jones, R.N. 2000: In vitro activity of ceftiofur tested against clinical isolates of Escherichia coli and Klebsiella pneumoniae including extended spectrum beta-lactamase producing strains. International Journal of Antimicrobial Agents 15(4): 271-275

Johnson, A.P.; Warner, M.; Carter, M.; Livermore, D.M. 2002: In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci. Antimicrobial Agents and ChemoTherapy 46(2): 321-326

Miyashita, N.; Fukano, H.; Yoshida, K.; Niki, Y.; Matsushima, T. 2003: In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. Journal of Antimicrobial ChemoTherapy 52(3): 497-499

Isenberg, H.D.; Alperstein, P.; France, K. 1999: In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia. Diagnostic Microbiology and Infectious Disease 33(2): 81-86

Thangaraj, H.S.; Adjei, O.; Allen, B.W.; Portaels, F.; Evans, M.R.; Banerjee, D.K.; Wansbrough-Jones, M.H. 2000: In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. Journal of Antimicrobial ChemoTherapy 45(2): 231-233

Fuentes, F.; Sevillano, D.; Balcabao, I.P.; Gómez-Lus, M.L.; Prieto, J. 2000: In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation model. Journal of ChemoTherapy 12(6): 495-498

López-Brea, M.; Prieto, N.; Domingo, D.; de las Cuevas, C.; Sánchez, I.; Alarcón, T. 1999: In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates. International Journal of Antimicrobial Agents 12(1): 33-39

Ribera, A.; Jurado, A.; Ruiz, J.; Marco, F.; Del Valle, O.; Mensa, J.; Chaves, J.; Hernández, G.; Jiménez de Anta, M.Teresa.; Vila, J. 2002: In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine. Diagnostic Microbiology and Infectious Disease 42(2): 123-128

Duzkale, H.; Jilani, I.; Orsolic, N.; Zingaro, R.A.; Golemovic, M.; Giles, F.J.; Kantarjian, H.; Albitar, M.; Freireich, E.J.; Verstovsek, S. 2003: In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines. Cancer ChemoTherapy and Pharmacology 51(5): 427-432

Dhople, A.M. 1999: In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae. International Journal of Antimicrobial Agents 12(4): 319-323

Hilliard, N.J.; Johnson, C.N.; Armstrong, S.H.; Quarles, S.; Waites, K.B. 2002: In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials. International Journal of Antimicrobial Agents 20(2): 136-140

Friedland, I.; Mixson, L.A.; Majumdar, A.; Motyl, M.; Woods, G.L. 2002: In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics. Journal of ChemoTherapy 14(5): 483-491

Caniça, M.; Dias, R.; Louro, D.; Carvalho, C. 2002: In vitro activity of extended-spectrum cephalosporins against Streptococcus pneumoniae strains with reduced susceptibility to penicillin isolated from patients in Portugal between 1995 and 2000. Journal of Antimicrobial ChemoTherapy 50(4): 611-612

Milatovic, D.; Schmitz, F.-J.; Verhoef, J.; Fluit, A.C. 2002: In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe. Journal of Antimicrobial ChemoTherapy 50(2): 293-299

Du Plessis, M.; Capper, T.P.; Klugman, K.P. 2002: In vitro activity of faropenem against respiratory pathogens. Journal of Antimicrobial ChemoTherapy 49(3): 575-577

Schmitz, F.J.; Boos, M.; Mayer, S.; Verhoef, J.; Milatovic, D.; Fluit, A.C. 2001: In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae. Journal of Antimicrobial ChemoTherapy 48(1): 148-152

Credito, K.L.; Jacobs, M.R.; Appelbaum, P.C. 2003: In vitro activity of faropenem compared with eight agents against fourteen Gram-positive and Gram-negative bacteria by time-kill. Journal of Antimicrobial ChemoTherapy 51(6): 1437-1439

Girmenia, C.; Tuccinardi, C.; Santilli, S.; Mondello, F.; Monaco, M.; Cassone, A.; Martino, P. 2000: In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. Journal of Antimicrobial ChemoTherapy 46(3): 479-483

Bourgeois, N.; Ghnassia, J.-C.; Doucet-Populaire, F. 2003: In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis. Journal of Antimicrobial ChemoTherapy 51(3): 742-743

Grif, K.; Dierich, M.P.; Pfaller, K.; Miglioli, P.A.; Allerberger, F. 2001: In vitro activity of fosfomycin in combination with various antistaphylococcal substances. Journal of Antimicrobial ChemoTherapy 48(2): 209-217

Rodríguez, J.C.; Ruiz, M.; Climent, A.; Royo, G. 2001: In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis. International Journal of Antimicrobial Agents 17(3): 229-231

Swiatlo, E.; Moore, E.; Watt, J.; Mcdaniel, L.S. 2000: In vitro activity of four fluoroquinolones against clinical isolates of Pseudomonas aeruginosa determined by the E test. International Journal of Antimicrobial Agents 15(1): 73-76

Leclercq, R.; Bismuth, R.; Casin, I.; Cavallo, J.D.; Croizé, J.; Felten, A.; Goldstein, F.; Monteil, H.; Quentin-Noury, C.; Reverdy, M.; Vergnaud, M.; Roiron, R. 2000: In vitro activity of fusidic acid against streptococci isolated from skin and soft tissue infections. Journal of Antimicrobial ChemoTherapy 45(1): 27-29

Wexler, H.M.; Molitoris, D.; Finegold, S.M. 2001: In vitro activity of gatifloxacin against 238 strains of anaerobic bacteria. Anaerobe 7(6): 285-289

Reinert, R.R.; Al-Lahham, A.; Lemmen, S.; Lütticken, R. 2000: In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany. Journal of Antimicrobial ChemoTherapy 46(5): 854-856

Naber, K.G.; Hollauer, K.; Kirchbauer, D.; Witte, W. 2000: In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections. International Journal of Antimicrobial Agents 16(3): 239-243

Dubois, J.; St-Pierre, C. 1999: In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. Diagnostic Microbiology and Infectious Disease 33(4): 261-265

Goldstein, E.J.; Citron, D.M.; Warren, Y.; Tyrrell, K.; Merriam, C.V. 1999: In vitro activity of gemifloxacin (SB 265805) against anaerobes. Antimicrobial Agents and ChemoTherapy 43(9): 2231-2235

Hannan, P.C.; Woodnutt, G. 2000: In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. Journal of Antimicrobial ChemoTherapy 45(3): 367-369

Fernández-Roblas, R.; Cabria, F.; Esteban, J.; López, J.C.; Gadea, I.; Soriano, F. 2000: In vitro activity of gemifloxacin (SB-265805) compared with 14 other antimicrobials against intestinal pathogens. Journal of Antimicrobial ChemoTherapy 46(6): 1023-1027

Edelstein, P.H.; Shinzato, T.; Doyle, E.; Edelstein, M.A. 2001: In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and ChemoTherapy 45(8): 2204-2209

Minehart, H.W.; Chalker, A.F. 2001: In vitro activity of gemifloxacin against Helicobacter pylori. Journal of Antimicrobial ChemoTherapy 47(3): 360-361

Lemmen, S.; Al-Lahham, A.; Lütticken, R.; Reinert, R.R. 2001: In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany. ChemoTherapy 47(2): 104-109

McCloskey, L.; Moore, T.; Niconovich, N.; Donald, B.; Broskey, J.; Jakielaszek, C.; Rittenhouse, S.; Coleman, K. 2000: In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA. Journal of Antimicrobial ChemoTherapy 45(Suppl 1): 13-21

Ruiz, J.; Marco, F.; Sierra, J.M.; Aguilar, L.; Garcia-Mendez, E.; Mensa, J.; Jiménez De Anta, M.Teresa.; Vila, J. 2003: In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene. International Journal of Antimicrobial Agents 22(1): 73-76

Yong, D.Eun.; Cheong, H-Jin.; Kim, Y.Soo.; Park, Y.Joon.; Kim, W-Joo.; Woo, J.Hee.; Lee, K.Won.; Kang, M.Won.; Choo, Y-Sung. 2002: In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea. Journal of Korean Medical Science 17(6): 737-742

Mortensen, J.E.; Rodgers, G.L. 2000: In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis. Journal of Antimicrobial ChemoTherapy 45(Suppl): 47-49

Goldstein, E.J.C.; Conrads, G.; Citron, D.M.; Merriam, C.V.; Warren, Y.; Tyrrell, K. 2002: In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. Diagnostic Microbiology and Infectious Disease 42(2): 113-118

Ieven, M.; Goossens, W.; De Wit, S.; Goossens, H. 2000: In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci. Journal of Antimicrobial ChemoTherapy 45(Suppl 1): 51-53

Styczynski, J.; Wysocki, M.; Kurylak, A.; Juraszewska, E.; Malinowska, I.; Stanczak, E.; Płoszynska, A.; Stefaniak, J.; Mazur, B.; Szczepanski, T.; Ras, M. 2002: In vitro activity of glufosfamide in childhood acute leukemia. Anticancer Research 22(1a): 247-250

Engler, K.H.; Warner, M.; George, R.C. 2001: In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae. Journal of Antimicrobial ChemoTherapy 47(1): 27-31

Giovanetti, E.; Montanari, M.P.; Marchetti, F.; Varaldo, P.E. 2000: In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Journal of Antimicrobial ChemoTherapy 46(6): 905-908

Cafiso, V.; Messina, C.; Santagati, M.; Campanile, F.; Bonfiglio, G.; Stefani, S. 2001: In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci. Drugs under Experimental and Clinical Research 27(3): 107-111

Montanari, M.P.; Mingoia, M.; Marchetti, F.; Varaldo, P.E. 1999: In vitro activity of levofloxacin against gram-positive bacteria. ChemoTherapy 45(6): 411-417

Biedenbach, D.J.; Jones, R.N. 2001: In vitro activity of linezolid (U-100766) against Haemophilus influenzae measured by three different susceptibility testing methods. Diagnostic Microbiology and Infectious Disease 39(1): 49-53

Szczypa, K.; Betlejewska, K.; Nowak, K.; Hryniewicz, K. 2001: In vitro activity of linezolid against Gram-positive cocci isolated in Poland. Journal of Antimicrobial ChemoTherapy 48(6): 932-935

Bowker, K.E.; Wootton, M.; Holt, H.A.; MacGowan, A.P. 2002: In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patients. Journal of Antimicrobial ChemoTherapy 49(3): 578-580

Onda, H.; Wagenlehner, F.M.; Lehn, N.; Naber, K.G. 2001: In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections. International Journal of Antimicrobial Agents 18(3): 263-266

Fang, C.T.; Chang, S.C.; Chen, Y.C.; Hsieh, S.M.; Hsieh, W.C. 2001: In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance. International Journal of Antimicrobial Agents 18(3): 267-270

Cercenado, E.; García-Garrote, F.; Bouza, E. 2001: In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. Journal of Antimicrobial ChemoTherapy 47(1): 77-81

Brown-Elliott, B.A.; Crist, C.J.; Mann, L.B.; Wilson, R.W.; Wallace, R.J. 2003: In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria. Antimicrobial Agents and ChemoTherapy 47(5): 1736-1738

Patel, R.; Rouse, M.S.; Piper, K.E.; Steckelberg, J.M. 1999: In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 34(2): 119-122

Tubau, F.; Fernández-Roblas, R.; Liñares, J.; Martín, R.; Soriano, F. 2001: In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods. Journal of Antimicrobial ChemoTherapy 47(5): 675-680

Abb, J. 2002: In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: Comparative evaluation by the E test and a broth microdilution method. Diagnostic Microbiology and Infectious Disease 43(4): 319-321

Muñoz Bellido, J.L.; Gutiérrez Zufiaurre, M.N.; Sánchez Hernández, F.J.; Yagüe Guirao, G.; Segovia Hernández, M.; García-Rodríguez, J.A. 2002: In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents 20(1): 61-64

Christenson, J.C.; Korgenski, E.K.; Daly, J.A. 2000: In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Journal of Antimicrobial ChemoTherapy 45(6): 899-901

Pereyre, S.; de Barbeyrac, B.; Renaudin, H.; Poutiers, F.; Bébéar, C.; Bébéar, C.M. 2001: In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae. Journal of Antimicrobial ChemoTherapy 47(2): 240-241

Conti, S.; Magliani, W.; Arseni, S.; Dieci, E.; Frazzi, R.; Salati, A.; Varaldo, P.E.; Polonelli, L. 2000: In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci. Molecular Medicine 6(7): 613-619

Wexler, H.M.; Molitoris, E.; Molitoris, D.; Finegold, S.M. 2000: In vitro activity of moxifloxacin against 179 strains of anaerobic bacteria found in pulmonary infections. Anaerobe 6(4): 227-231

Sobottka, I.; Cachovan, G.; Stürenburg, E.; Ahlers, M.Oliver.; Laufs, R.; Platzer, U.; Mack, D. 2002: In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrobial Agents and ChemoTherapy 46(12): 4019-4021

Sheng, W.H.; Wang, J.T.; Chen, Y.C.; Chang, S.C.; Luh, K.T. 2001: In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan. Journal of Microbiology Immunology and Infection 34(3): 178-184

Decousser, J.W.; Allouch, P-Y.; Courvalin, P.; Leclercq, R. 2002: In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: A national survey. International Journal of Antimicrobial Agents 20(3): 186-195

Malathum, K.; Singh, K.V.; Murray, B.E. 1999: In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria. Diagnostic Microbiology and Infectious Disease 35(2): 127-133

Rodríguez, J.C.; Ruiz, M.; López, M.; Royo, G. 2002: In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. International Journal of Antimicrobial Agents 20(6): 464-467

Schmitz, F.-J.; Petridou, J.; Milatovic, D.; Verhoef, J.; Fluit, A.C.; Schwarz, S. 2002: In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status. Journal of Antimicrobial ChemoTherapy 49(3): 580-582

Alonso, R.; Peláez, T.; González-Abad, M.J.; Alcalá, L.; Muñoz, P.; Rodríguez-Créixems, M.; Bouza, E. 2001: In vitro activity of new quinolones against Clostridium difficile. Journal of Antimicrobial ChemoTherapy 47(2): 195-197

Bellido, J.L.; Hernández, F.J.; Zufiaurre, M.N.; García-Rodríguez, J.A. 2000: In vitro activity of newer fluoroquinolones against Stenotrophomonas maltophilia. Journal of Antimicrobial ChemoTherapy 46(2): 334-335

Jones, R.N.; Pfaller, M.A. 2000: In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 31 Suppl. 2: S16-S23

Yagupsky, P.; Katz, O.; Peled, N.; Dagan, R. 2001: In vitro activity of novel fluoroquinolones against Streptococcus pneumoniae isolated from children with acute otitis media. ChemoTherapy 47(5): 354-358

Styczyński, J.; Wysocki, M.; Debski, R.; Balwierz, W.; Rokicka-Milewska, R.; Matysiak, Mł.; Balcerska, A.; Kowalczyk, J.; Wachowiak, J.; Sońta-Jakimczyk, D.; Chybicka, A. 2002: In vitro activity of oxazaphosphorines in childhood acute leukemia: preliminary report. Acta biochimica Polonica 49(1): 221-225

Wenzler, S.; Schmidt-Eisenlohr, E.; Daschner, F. 2003: In vitro activity of penicillin G/sulbactam compared with penicillin and other antibiotics against common organisms causing ear, nose and throat (ENT) infections. Journal of Antimicrobial ChemoTherapy 51(5): 1312-1314

Livermore, D.M.; Mushtaq, S.; James, D.; Potz, N.; Walker, R.A.; Charlett, A.; Warburton, F.; Johnson, A.P.; Warner, M.; Henwood, C.J. 2003: In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles. International Journal of Antimicrobial Agents 22(1): 14-27

Kaiser, L.; Crump, C.E.; Hayden, F.G. 2000: In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Research 47(3): 215-220

Kern, E.R. 2003: In vitro activity of potential anti-poxvirus agents. Antiviral Research 57(1-2): 35-40

Pradines, B.; Tall, A.; Fusai, T.; Spiegel, A.; Rogier, R.; Trape, J.F.; Parzy, D. 1998: In vitro activity of pyronaridine against African isolates (Senegal) of Plasmodium falciparum. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1998(19): 37-38

Edelstein, P.H.; Edelstein, M.A. 2000: In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp. Diagnostic Microbiology and Infectious Disease 36(1): 49-52

Chang, S.C.; Fang, C.T.; Hsueh, P.R.; Luh, K.T.; Hsieh, W.C. 1999: In vitro activity of quinupristin/dalfopristin against clinical isolates of common Gram-positive bacteria in Taiwan. Diagnostic Microbiology and Infectious Disease 33(4): 299-303

Reinert, R.R.; Kresken, M.; Mechery, V.; Lemperle, M.; Lütticken, R. 1998: In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 17(9): 662-665

John, M.A.; Pletch, C.; Hussain, Z. 2002: In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci. Journal of Antimicrobial ChemoTherapy 50(6): 933-938

Chien, H.P.; Yu, M.C.; Ong, T.F.; Lin, T.P.; Luh, K.T. 2000: In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan. Journal of the Formosan Medical Association 99(5): 408-411

Fujimura, S.; Kato, S.; Kawamura, T.; Watanabe, A. 2002: In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults. Journal of Antimicrobial ChemoTherapy 49(3): 541-543

Zheng-Bo; Li-Jia-Tai 2001: In vitro activity of rifamycin and other 5 antibiotics against Staphylococcus aureus. Zhongguo Kangshengsu Zazhi 26(4): 290-291, 317

Sierra, J.M.; Navia, M.M.; Vargas, M.; Urassa, H.; Schellemberg, D.; Gascón, J.; Vila, J.; Ruiz, J. 2001: In vitro activity of rifaximin against bacterial enteropathogens causing diarrhoea in children under 5 years of age in Ifakara, Tanzania. Journal of Antimicrobial ChemoTherapy 47(6): 904-905

Marchese, A.; Salerno, A.; Pesce, A.; Debbia, E.A.; Schito, G.C. 2000: In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species. ChemoTherapy 46(4): 253-266

Marone, P.; Monzillo, V.; Carretto, E.; Haeusler, E.; Antoniazzi, E. 2002: In vitro activity of sagamicin against ocular bacterial isolates. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 216(2): 133-138

Jones, R.N.; Jenkins, S.G.; Hoban, D.J.; Pfaller, M.A.; Ramphal, R. 2000: In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. Diagnostic Microbiology and Infectious Disease 37(2): 93-98

Palacín, C.; Tarragó, C.; Agut, J.; Guglietta, A. 2001: In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods and Findings in Experimental and Clinical Pharmacology 23(2): 61-64

Blondeau, J.M.; Church, D.; Yaschuk, Y.; Bjarnason, J. 1999: In vitro activity of several antimicrobial agents against 1003 isolates of Streptococcus pyogenes collected from Western Canada. International Journal of Antimicrobial Agents 12(1): 67-70

Ackermann, G.; Tang, Y.J.; Rodloff, A.C.; Silva, J.; Cohen, S.H.; Heisig, P. 2001: In vitro activity of sitafloxacin against Clostridium difficile. Journal of Antimicrobial ChemoTherapy 47(5): 722-724

Jiang-Yufu; Zou-Qiyuan; Wang-Qinan; Hu-Peng; Qian-Yuanshu; Li-Chongzhi; Liu-Hongyu; Chen-Hai; Zheng-Xingping 1999: In vitro activity of sparfloxacin compared with those of five other antimicrobial agents. Zhongguo Kangshengsu Zazhi 24(6): 472-475

Majtan, V.; Majtanova, L. 1998: In vitro activity of subinhibitory concentrations of quinolones on the surface hydrophobicity of Enterobacter cloacae. Microbios 95(381): 117-123

Ramharter, M.; Noedl, H.; Thimasarn, K.; Wiedermann, G.; Wernsdorfer, G.; Wernsdorfer, W.H. 2002: In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 67(1): 39-43

Wexler, H.M.; Molitoris, E.; Molitoris, D.; Finegold, S.M. 2001: In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria. Journal of Antimicrobial ChemoTherapy 47(4): 467-469

Ackermann, G.; Schaumann, R.; Pless, B.; Claros, M.C.; Rodloff, A.C. 2000: In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria. Journal of Antimicrobial ChemoTherapy 46(1): 115-119

Yamaguchi, T.; Hirakata, Y.; Izumikawa, K.; Miyazaki, Y.; Maesaki, S.; Tomono, K.; Yamada, Y.; Kamihira, S.; Kohno, S. 2000: In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan. Antimicrobial Agents and ChemoTherapy 44(5): 1381-1382

Morosini, M.I.; Cantón, R.; Loza, E.; Negri, M.C.; Galán, J.C.; Almaraz, F.; Baquero, F. 2001: In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. Antimicrobial Agents and ChemoTherapy 45(9): 2427-2431

Fuchs, P.C.; Barry, A.L.; Brown, S.D. 2002: In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime. Journal of Antimicrobial ChemoTherapy 49(2): 399-401

Miyashita, N.; Fukano, H.; Niki, Y.; Matsushima, T. 2001: In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae. Journal of Antimicrobial ChemoTherapy 48(3): 403-405

Schülin, T. 2002: In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany. Journal of Antimicrobial ChemoTherapy 49(2): 403-406

Guarino, L.A.; Dong, W.; Jin, J. 2002: In vitro activity of the baculovirus late expression factor LEF-5. Journal of Virology 76(24): 12663-12675

Murugasu-Oei, B.; Dick, T. 2001: In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG. International Journal of Antimicrobial Agents 18(6): 579-582

Casellas, Jé.María.; Tomé, G.; Visser, Mías.; Gliosca, L. 2002: In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci. Diagnostic Microbiology and Infectious Disease 42(2): 107-112

Torres, C.; Zarazaga, M.; Tenorio, C.; Portillo, A.; Saenz, Y.; Ruiz, F.; Baquero, F. 1998: In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp. Antimicrobial Agents and ChemoTherapy 42(12): 3279-3281

Bemer-Melchior, P.; Juvin, M.E.; Tassin, S.; Bryskier, A.; Schito, G.C.; Drugeon, H.B. 2000: In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrobial Agents and ChemoTherapy 44(11): 2999-3002

Alcalá, L.; Cercenado, E.; García-Garrote, F.; Bouza, E. 1999: In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates. Diagnostic Microbiology and Infectious Disease 33(1): 27-31

Frost, B.-M.; Lönnerholm, G.; Nygren, P.; Larsson, R.; Lindhagen, E. 2002: In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia. Anti-Cancer Drugs 13(7): 735-742

Schmitz, F.-J.; Milatovic, D.; Boos, M.; Mayer, S.; Fluit, A.C. 2002: In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility. Journal of Antimicrobial ChemoTherapy 49(4): 698-701

Hoban, D.J.; Zhanel, G.G.; Karlowsky, J.A. 1999: In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Diagnostic Microbiology and Infectious Disease 35(1): 37-44

Marchese, A.; Debbia, E.A.; Tonoli, E.; Gualco, L.; Schito, A.M. 2002: In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in Italy. Journal of ChemoTherapy 14(6): 554-561

Cercenado, E.; Cercenado, S.; Gómez, J.A.; Bouza, E. 2003: In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides. Journal of Antimicrobial ChemoTherapy 52(1): 138-139

Ling, T.K.; Liu, E.Y.; Cheng, A.F. 1999: In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates. ChemoTherapy 45(1): 22-27

Stearne, L.E.T.; Kooi, C.; Goessens, W.H.F.; Bakker Woudenberg, I.A.J.M.; Gyssens, I.C. 2001: In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique. Antimicrobial Agents and Chemotherapy 45(1): 243-251

Fuchs, P.C.; Barry, A.L.; Brown, S.D. 1999: In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test. Diagnostic Microbiology and Infectious Disease 33(1): 33-38

Bebear, C.M.; Renaudin, H.; Charron, A.; Gruson, D.; Lefrancois, M.; Bebear, C. 2000: In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrobial Agents and ChemoTherapy 44(9): 2557-2560

Rossi, A.; Galas, M.; Tokumoto, M.; Guelfand, L.; Lopardo, H.; Grupo-Colaborativo-Whonet-Argentina 1999: In vitro activity of trovafloxacin, of other fluoroquinolones and of related antimicrobials against clinical isolates. Medicina (Buenos Aires) 59(Suppl 1): 8-16

Landini, I.; Bartolozzi, B.; Banchelli, I.; Degli Innocenti, A.; Nocentini, O.; Bernabei, P.A. 2001: In vitro activity of vinorelbine on human leukemia cells. Journal of ChemoTherapy 13(3): 309-315

De-Souza, A.-Olivia; Girello-Aily, D.-Cristina; Sato, D.-Nakamura; Duran, N. 1999: In vitro activity of violacein against Mycobacterium tuberculosis H37Ra. Revista do Instituto Adolfo Lutz 58(1): 59-62

Serrano, Mía.del.Carmen.; Valverde-Conde, A.; Chávez M, Mónica.; Bernal, S.; Claro, R.María.; Pemán, J.; Ramirez, M.; Martín-Mazuelos, E. 2003: In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagnostic Microbiology and Infectious Disease 45(2): 131-135

Miyamoto, Y.; Teramoto, N.; Imanishi, Y.; Ito, Y. 2001: In vitro adaptation of a ligase ribozyme for activity under a low-pH condition. Biotechnology and Bioengineering 75(5): 590-596

Noort, D.; Hulst, A.G.; Fidder, A.; van Gurp, R.A.; de Jong, L.P.; Benschop, H.P. 2000: In vitro adduct formation of phosgene with albumin and hemoglobin in human blood. Chemical Research in Toxicology 13(8): 719-726

König, D.P.; Schierholz, J.M.; Hilgers, R.D.; Bertram, C.; Perdreau-Remington, F.; Rütt, J. 2001: In vitro adherence and accumulation of Staphylococcus epidermidis RP 62 a and Staphylococcus epidermidis M7 on four different bone cements. Langenbeck's Archives of Surgery 386(5): 328-332

Joyanes, P.; Pascual, A.; Martínez-Martínez, L.; Hevia, A.; Perea, E.J. 2000: In vitro adherence of Enterococcus faecalis and Enterococcus faecium to urinary catheters. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 19(2): 124-127

Pinna, A.; Zanetti, S.; Sechi, L.A.; Usai, D.; Falchi, M.P.; Carta, F. 2000: In vitro adherence of Staphylococcus epidermidis to polymethyl methacrylate and Acrysof intraocular lenses. Ophthalmology 107(6): 1042-1046

Wong, D.; Prameya, R.; Dorovini-Zis, K. 1999: In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. Journal of Neuropathology and Experimental Neurology 58(2): 138-152

Pruzzo, C.; Tarsi, R.; Lleò, M.M.; Signoretto, C.; Zampini, M.; Colwell, R.R.; Canepari, P. 2002: In vitro adhesion to human cells by viable but nonculturable Enterococcus faecalis. Current Microbiology 45(2): 105-110

Archimbaud, C.; Shankar, N.; Forestier, C.; Baghdayan, A.; Gilmore, M.S.; Charbonné, Fçoise.; Joly, B. 2002: In vitro adhesive properties and virulence factors of Enterococcusfaecalis strains. Research in Microbiology 153(2): 75-80

Rodrigues, M.; Chehne, F.; Sinzinger, H. 2001: In vitro adsorption of 99Tc(m)-MIBI, 99Tc(m)-tetrofosmin, 99Tc(m)-furifosmin and 99Tc(m)O4- onto tubes. Nuclear Medicine Communications 22(1): 105-110

Ponampalam, R.; Otten, E.J. 2002: In vitro adsorption of lithium by bentonite. Singapore Medical Journal 43(2): 086-089

Lange, C.F.; Hancock, R.E.; Samuel, J.; Finlay, W.H. 2001: In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. Journal of Pharmaceutical Sciences 90(10): 1647-1657

Pancook, J.D.; Beuerlein, G.; Pecht, G.; Tang, Y.; Nie, Y.; Wu, H.; Huse, W.D.; Watkins, J.D. 2001: In vitro affinity maturation of human IgM antibodies reactive with tumor-associated antigens. Hybridoma and Hybridomics 20(5-6): 383-396

Dezutter, N.A.; Sciot, R.M.; de Groot, T.J.; Bormans, G.M.; Verbruggen, A.M. 2001: In vitro affinity of 99Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis. Nuclear Medicine Communications 22(5): 553-558

Grover, L.M.; Knowles, J.C.; Fleming, G.J.P.; Barralet, J.E. 2003: In vitro ageing of brushite calcium phosphate cement. Biomaterials 24(23): 4133-4141

Jain, R.K.; Chang, W.T.; Geetha, C.; Joyce, P.B.M.; Gorr, S.-U. 2002: In vitro aggregation of the regulated secretory protein chromogranin a. Biochemical Journal 368(Part 2): 605-610

Petitot, F.; Lebeau, Jérôme.; Dano, L.; Lectard, B.; Altmeyer, S.; Levalois, Céline.; Chevillard, S. 2003: In vitro aging of rat lung cells. Downregulation of telomerase activity and continuous decrease of telomere length are not incompatible with malignant transformation. Experimental Cell Research 286(1): 30-39

Janssen, L.J.; Djurić, V.J.; Wattie, J.; Otis, J.; O'Byrne, P.M. 2000: In vitro airway responsiveness of Flinders sensitive and resistant line rats. Brain Behavior and Immunity 14(1): 62-67

Cassinat, B.; Chevret, S.; Zassadowski, F.; Balitrand, N.; Guillemot, I.; Menot, M.L.; Degos, L.; Fenaux, P.; Chomienne, C. 2001: In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 98(9): 2862-2864

Liappis, N.; Starke, A. 1999: In vitro allergy screening in serum of children. Distribution of specific IgE antibodies in SX1 and fx5 positive sera. Allergologie 22(6): 388-391

Monneron, M.C.; Gillberg, P.G.; Ohman, B.; Alberts, P. 2000: In vitro alpha-adrenoceptor autoradiography of the urethra and urinary bladder of the female pig, cat, guinea-pig and rat. Scandinavian Journal of Urology and Nephrology 34(4): 233-238

Chu, X.; Newman, J.; Park, B.; Nares, S.; Ordonez, G.; Iacopino, A.M. 1999: In vitro alteration of macrophage phenotype and function by serum lipids. Cell and Tissue Research 296(2): 331-337

Araki, Y.; Andoh, A.; Fujiyama, Y.; Itoh, A.; Bamba, T. 2002: In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions. International Journal of Molecular Medicine 9(6): 627-631

Saroja, N.-Rao; Tharanathan, R.-Narayanaswamy 2000: In vitro amylolytic degradation of natural and graft copolymerised cassava and potato starches. European Food Research and Technology 211(6): 411-414

Nargeot, R.; Baxter, D.A.; Byrne, J.H. 1999: In vitro analog of operant conditioning in aplysia. I. Contingent reinforcement modifies the functional dynamics of an identified neuron. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(6): 2247-2260

Nargeot, R.; Baxter, D.A.; Byrne, J.H. 1999: In vitro analog of operant conditioning in aplysia. II. Modifications of the functional dynamics of an identified neuron contribute to motor pattern selection. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 19(6): 2261-2272

Gutensohn, K.; Beythien, C.; Bau, J.; Fenner, T.; Grewe, P.; Koester, R.; Padmanaban, K.; Kuehnl, P. 2000: In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thrombosis Research 99(6): 577-585

Michaud, Jëlle.; Wu, F.; Osato, M.; Cottles, G.M.; Yanagida, M.; Asou, N.; Shigesada, K.; Ito, Y.; Benson, K.F.; Raskind, W.H.; Rossier, C.; Antonarakis, S.E.; Israels, S.; McNicol, A.; Weiss, H.; Horwitz, M.; Scott, H.S. 2002: In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 99(4): 1364-1372

Sourmeli, S.; Kravariti, L.; Lecanidou, R. 2003: In vitro analysis of Bombyx mori early chorion gene regulation: stage specific expression involves interactions with C/EBP-like and GATA factors. Insect Biochemistry and Molecular Biology 33(5): 525-540

Haley, B.; Tang, G.; Zamore, P.D. 2003: In vitro analysis of RNA interference in Drosophila melanogaster. Methods 30(4): 330-336

Sakurai, Y.; Arai, K.; Watanabe, S. 2000: In vitro analysis of STAT5 activation by granulocyte-macrophage colony-stimulating factor. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 5(11): 937-947

Ahmad, I.; Dooley, C.M.; Thoreson, W.B.; Rogers, J.A.; Afiat, S. 1999: In vitro analysis of a mammalian retinal progenitor that gives rise to neurons and glia. Brain Research 831(1-2): 1-10

Colomer Pallas, A.; Petit Glatron, M.F.; Chambert, R. 2002: In vitro analysis of aggregation-disaggregation of the folding intermediate of Bacillus subtilis alpha-amylase. Journal of Biological Chemistry 2(3-4): 101-107

Laufer, G.; Schaaf, G.; Bollgönn, S.; Günzl, A. 1999: In vitro analysis of alpha-amanitin-resistant transcription from the rRNA, procyclic acidic repetitive protein, and variant surface glycoprotein gene promoters in Trypanosoma brucei. Molecular and Cellular Biology 19(8): 5466-5473

Grayson, C.; Chapple, J.P.; Willison, K.R.; Webster, A.R.; Hardcastle, A.J.; Cheetham, M.E. 2002: In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients. Journal of Medical Genetics 39(1): 62-67

Marra, K.G.; Szem, J.W.; Kumta, P.N.; Dimilla, P.A.; Weiss, L.E. 1999: In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. Journal of Biomedical Materials Research 47(3): 324-335

Jiang, X. 2000: In vitro analysis of cell death of spinal oligodendrocytes in a rat model of HTLV-I infection. Hokkaido Journal of Medical Science 75(5): 335-346

Iwanochko, R.M.; Hiscoke, B.; Sellens, R.W.; Small, C.F.; Sanfilippo, A.J. 1999: In vitro analysis of colour Doppler flow with the use of proximal isovelocity surface area: improved flow estimates using a nonhemispherical model. Canadian Journal of Cardiology 15(1): 89-94

Palmer, N.D.; Northridge, D.; Lessells, A.; McDicken, W.N.; Fox, K.A. 1999: In vitro analysis of coronary atheromatous lesions by intravascular ultrasound; reproducibility and histological correlation of lesion morphology. European Heart Journal 20(23): 1701-1706

Wengler, G.; Wengler, G. 2002: In vitro analysis of factors involved in the disassembly of Sindbis virus cores by 60S ribosomal subunits identifies a possible role of low pH. Journal of General Virology 83(Pt 10): 2417-2426

Soars, M.G.; Burchell, B.; Riley, R.J. 2002: In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. Journal of Pharmacology and Experimental Therapeutics 301(1): 382-390

Driscoll, M.D.; Golinelli, M.P.; Hughes, S.H. 2001: In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing. Journal of Virology 75(2): 672-686

Koike, T.; Yasugi, S. 1999: In vitro analysis of mesenchymal influences on the differentiation of stomach epithelial cells of the chicken embryo. Differentiation; Research in Biological Diversity 65(1): 13-25

Distasi, C.; Ariano, P.; Zamburlin, P.; Ferraro, M. 2002: In vitro analysis of neuron-glial cell interactions during cellular migration. European Biophysics Journal: Ebj 31(2): 81-88

Schmitt, I.; Gerace, L. 2001: In vitro analysis of nuclear transport mediated by the C-terminal shuttle domain of Tap. Journal of Biological Chemistry 276(45): 42355-42363

Lozano, M.L.; Rivera, J.; Bermejo, E.; Corral, J.; Pérez, E.; Vicente, V. 2000: In vitro analysis of platelet concentrates stored in the presence of modulators of 3',5' adenosine monophosphate, and organic anions. Transfusion Science 22(1-2): 3-11

Kim, S.; Sim, S.; Lee, Y. 1999: In vitro analysis of processing at the 3'-end of precursors of M1 RNA, the catalytic subunit of Escherichia coli RNase P: multiple pathways and steps for the processing. Nucleic Acids Research 27(3): 895-902

Delvecchio, F.C.; Auge, B.K.; Brizuela, R.M.; Weizer, A.Z.; Zhong, P.; Preminger, G.M. 2003: In vitro analysis of stone fragmentation ability of the FREDDY laser. Journal of Endourology 17(3): 177-179

Ohman, M.; Källman, A.M.; Bass, B.L. 2000: In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site. Rna 6(5): 687-697

Takahashi, S.; Hagiwara, T.; Shiga, S.; Takaoki Hirose, T.; Tsukamoto, T. 2000: In vitro analysis of the change in resistance of Chlamydia trachomatis under exposure to sub-MIC levofloxacin for a therapeutic term. ChemoTherapy 46(6): 402-407

Ryder, J.W.; Kawano, Y.; Chibalin, A.V.; Rincón, J.; Tsao, T.S.; Stenbit, A.E.; Combatsiaris, T.; Yang, J.; Holman, G.D.; Charron, M.J.; Zierath, J.R. 1999: In vitro analysis of the glucose-transport system in GLUT4-null skeletal muscle. Biochemical Journal 342: 321-328

Jerome, L.J.; Frost, L.S. 1999: In vitro analysis of the interaction between the FinO protein and FinP antisense RNA of F-like conjugative plasmids. Journal of Biological Chemistry 274(15): 10356-10362

Fonsatti, E.; Lamaj, E.; Coral, S.; Sigalotti, L.; Nardi, G.; Gasparollo, A.; Colombo, M.P.; Altomonte, M.; Maio, M. 1999: In vitro analysis of the melanoma/endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cells. Cancer Immunology Immunotherapy: Cii 48(2-3): 132-138

Hatanaka, Y.; Murakami, F. 2002: In vitro analysis of the origin, migratory behavior, and maturation of cortical pyramidal cells. Journal of Comparative Neurology 454(1): 1-14

Fabre, M.; Martin, M.; Ulloa, F.; Real, F.X. 1999: In vitro analysis of the role of DCC in mucus-secreting intestinal differentiation. International Journal of Cancer 81(5): 799-807

Matsuoka, H.; Akiyama, H.; Okada, Y.; Ito, H.; Shigeno, C.; Konishi, J.; Kokubo, T.; Nakamura, T. 1999: In vitro analysis of the stimulation of bone formation by highly bioactive apatite- and wollastonite-containing glass-ceramic: Released calcium ions promote osteogenic differentiation in osteoblastic ROS17/2.8 cells. Journal of Biomedical Materials Research 47(2): 176-188

Del Solar, G.; Espinosa, M. 2001: In vitro analysis of the terminator T(II) of the inhibitor antisense rna Ii gene from plasmid pMV158. Plasmid 45(2): 75-87

Dong, J.; Park, J.S.; Lee, S.H. 1999: In vitro analysis of the zinc-finger motif in human replication protein a. Biochemical Journal 337: 311-317

Kang, C.J.; Peterson, D.O. 2001: In vitro analysis of transcriptional repression of the mouse mammary tumor virus promoter. Biochemical and Biophysical Research Communications 287(2): 402-410

Powell, S.K.; Kaloss, M.; Burimski, I.; Weaver, L.; Long, Z.; Lyons, R.; McGarrity, G.J.; Otto, E. 1999: In vitro analysis of transformation potential associated with retroviral vector insertions. Human Gene Therapy 10(13): 2123-2132

Rivers, D.B.; Genco, M.; Sanchez, R.A. 1999: In vitro analysis of venom from the wasp Nasonia vitripennis: susceptibility of different cell lines and venom-induced changes in plasma membrane permeability. In Vitro Cellular and Developmental Biology. Animal 35(2): 102-110

Blaheta, R.A.; Hailer, N.P.; Brude, N.; Wittig, B.; Leckel, K.; Oppermann, E.; Bachmann, M.; Harder, S.; Cinatl, J.; Scholz, M.; Bereiter-Hahn, J.; Weber, S.; Encke, A.; Markus, B.H. 2000: In vitro analysis of verapamil-induced immunosuppression: potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells. Transplantation 69(4): 588-597

Cheng, S-L.; Lou, J.; Wright, N.M.; Lai, C.F.; Avioli, L.V.; Riew, K.D. 2001: In vitro and In vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcified Tissue International 68(2): 87-94

Nesbit, C.E.; Schwartz, S.A. 2002: In vitro and animal models of human immunodeficiency virus infection of the central nervous system. Clinical and Diagnostic Laboratory Immunology 9(3): 515-524

Nagy, Z.; Sipka, R.; Ocsovszki, I.; Balogh, A.; Mándi, Y. 1998: In vitro and clinical effect of pentoxifylline on natural killer cell activity. Orvosi Hetilap 139(41): 2441-2445

Håberg, A.; Qu, H.; Bakken, I.J.; Sande, L.M.; White, L.R.; Haraldseth, O.; Unsgård, G.; Aasly, J.; Sonnewald, U. 1998: In vitro and ex vivo 13C-NMR spectroscopy studies of pyruvate recycling in brain. Developmental Neuroscience 20(4-5): 389-398

Raad, I.; Chatzinikolaou, I.; Chaiban, G.; Hanna, H.; Hachem, R.; Dvorak, T.; Cook, G.; Costerton, W. 2003: In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrobial Agents and ChemoTherapy 47(11): 3580-3585

Ortega, E.; Escobar, M..Antonia.; de Cienfuegos, G.Alvarez. 2002: In vitro and ex vivo effects of erythromycin A, azithromycin and josamycin on the splenic response to specific antigens and mitogens. Journal of Antimicrobial ChemoTherapy 49(6): 1031-1034

Rols, M.P.; Delteil, C.; Golzio, M.; Teissie, J. 1998: In vitro and ex vivo electrically mediated permeabilization and gene transfer in murine melanoma. Bioelectrochemistry and Bioenergetics 47(1): 129-134

Wu, H-Tien.; Lin, C-Sheng.; Huang, M-Chiou. 2003: In vitro and ex vivo green fluorescent protein expression in alveolar mammary epithelial cells and mammary glands driven by the distal 5'-regulative sequence and intron 1 of the goat beta-casein gene. Reproduction Fertility and Development 15(4): 231-239

Shukalyuk, A.I.; Isaeva, V.V. 2000: In vitro and histological investigation of the rhizocephalan crustacean Sacculina polygenea interna. Russian Journal of Marine Biology 26(3): 200-202

Vladychenskaya, I.P.; Dergunova, L.V.; Limborska, S.A. 2002: In vitro and in silico analysis of the predicted human MOB gene encoding a phylogenetically conserved transmembrane protein. Biomolecular Engineering 18(6): 263-268

Crowe, A.; Lemaire, M. 1998: In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: Comparison with rapamycin. Pharmaceutical Research 15(11): 1666-1672

Mora, O.; Romano, J., L.; Gonzalez, E.; Ruiz, F., J.; Shimada, A. 1999: In vitro and in situ disappearance of beta-carotene and lutein from lucerne (Medicago sativa) hay in bovine and caprine ruminal fluids. Journal of the Science of Food and Agriculture 79(2): 273-276

Rémy, M.; Valli, N.; Brethes, D.; Labrugère, C.; Porté-Durrieu, M.C.; Dobrova, N.B.; Novikova, S.P.; Gorodkov, A.J.; Bordenave, L. 1999: In vitro and in situ intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells lining a polyester fabric. Biomaterials 20(3): 241-251

Lowther, N.; Fox, R.; Faller, B.; Nick, H.; Jin, Y.; Sergejew, T.; Hirschberg, Y.; Oberle, R.; Donnelly, H. 1999: In vitro and in situ permeability of a 'second generation' hydroxypyridinone oral iron chelator: Correlation with physico-chemical properties and oral activity. Pharmaceutical Research 16(3): 434-440

Kim, K.Soo.; Jacob, N.; Stohl, W. 2003: In vitro and in vivo T cell oligoclonality following chronic stimulation with staphylococcal superantigens. Clinical Immunology 108(3): 182-189

Autore, G.; Marzocco, S.; Sorrentino, R.; Mirone, V.G.; Baydoun, A.; Pinto, A. 1999: In vitro and in vivo TNFalpha synthesis modulation by methylguanidine, an uremic catabolyte. Life Sciences 65(11): Pl121-Pl127

Damianou, C. 2003: In vitro and in vivo ablation of porcine renal tissues using high-intensity focused ultrasound. Ultrasound in Medicine and Biology 29(9): 1321-1330

Ozmen, M.S.ner, S.M.te, A.K.cukbay, H. 1999: In vitro and in vivo acetylcholinesterase-inhibiting effect of new classes of organophosphorus compounds. Environmental toxicology and chemistry 18(2): 241-246

Albrecht, C.; Borm, P.J.A.; Adolf, B.; Timblin, C.R.; Mossman, B.T. 2002: In vitro and in vivo activation of extracellular signal-regulated kinases by coal dusts and quartz silica. Toxicology and Applied Pharmacology 184(1): 37-45

Schempp, C.M.; Simon-Haarhaus, B.; Heine, A.; Schöpf, E.; Simon, J.C. 1999: In vitro and in vivo activation of hypericin with the incoherent light source PDT 1200 SOA (520-750 nm) and with solar simulated radiation (290-2500 nm). Photodermatology Photoimmunology and Photomedicine 15(1): 13-17

Chen, F.S.; Scher, D.M.; Clancy, R.M.; Vera-Yu, A.; Di Cesare, P.E. 1999: In vitro and in vivo activation of polymorphonuclear leukocytes in response to particulate debris. Journal of Biomedical Materials Research 48(6): 904-912

Bataller, R.; Gasull, X.; Ginès, P.; Hellemans, K.; Görbig, M.N.; Nicolás, J.M.; Sancho-Bru, P.; De Las Heras, D.; Gual, A.; Geerts, A.; Arroyo, V.; Rodés, J. 2001: In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 33(4): 956-962

Jamieson, C.E.; Lambert, P.A.; Simpson, I.N. 2003: In vitro and in vivo activities of AM-112, a novel oxapenem. Antimicrobial Agents and ChemoTherapy 47(5): 1652-1657

Taylor, L.; Bachler, M.; Duncan, I.; Keen, S.; Fallon, R.; Mair, C.; McDonald, T.T.; Schwarz, H. 2002: In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions. Journal of Leukocyte Biology 72(3): 522-529

Nishida, K.; Kunugita, C.; Uji, T.; Higashitani, F.; Hyodo, A.; Unemi, N.; Maiti, S.N.; Phillips, O.A.; Spevak, P.; Atchison, K.P.; Salama, S.M.; Atwal, H.; Micetich, R.G. 1999: In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor. Antimicrobial Agents and ChemoTherapy 43(8): 1895-1900

Salama, S.M.; Atwal, H.; Gandhi, A.; Simon, J.; Poglod, M.; Montaseri, H.; Khan, J.K.; Furukawa, T.; Saito, H.; Nishida, K.; Higashitani, F.; Uji, T.; Unemi, N.; Daneshtalab, M.; Micetich, R.G. 2001: In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents. Antimicrobial Agents and ChemoTherapy 45(9): 2420-2426

Clark, J.; Fung-Tomc, J.C.; Minassian, B.; Tsai, Y-Hwang.; Yang, H.; Huczko, E.; Kolek, B.; Chaniewski, S.; Ferraro, C.; Drain, R.; Gradelski, E.; Bonner, D.P. 2002: In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci. Antimicrobial Agents and ChemoTherapy 46(4): 1108-1111